| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 6.26e-05 | 8 | 211 | 3 | GO:0022849 | |
| GeneOntologyMolecularFunction | NMDA glutamate receptor activity | 6.26e-05 | 8 | 211 | 3 | GO:0004972 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO5A MYO6 VWA8 ABCA12 NAIP MYO5C DDX11 ATP8A1 DQX1 ATP13A3 ABCC2 DNAH3 ATP13A1 MSH5 KIF20B DNAH17 UBA6 DHX32 | 9.71e-05 | 614 | 211 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | intracellular sodium-activated potassium channel activity | 1.11e-04 | 2 | 211 | 2 | GO:0005228 | |
| GeneOntologyMolecularFunction | amino acid sensor activity | 1.11e-04 | 2 | 211 | 2 | GO:0140785 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.23e-04 | 140 | 211 | 8 | GO:0099094 | |
| GeneOntologyMolecularFunction | molecular sensor activity | 1.81e-04 | 50 | 211 | 5 | GO:0140299 | |
| GeneOntologyMolecularFunction | glutamate binding | 3.89e-04 | 14 | 211 | 3 | GO:0016595 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | RAB19 VWA8 ABCA12 LRRK2 NAIP DDX11 ATP8A1 DQX1 ATP13A3 ABCC2 RAB29 RAC2 DNAH3 ATP13A1 SAR1A KIF20B SAR1B RASEF DHX32 | 5.96e-04 | 775 | 211 | 19 | GO:0017111 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYO5A MYO6 SPTBN2 LRRK2 BBS4 FMNL2 MYO5C GJA1 NF2 SYNE2 PLEC RAB29 CAMSAP2 ANK2 ANK3 CAPN1 FERMT1 KIF20B RHAG FMNL3 WASH3P KATNBL1 TRIM32 SNTB1 | 6.10e-04 | 1099 | 211 | 24 | GO:0008092 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | DAB2IP SPTBN2 ITGA9 ITGAM ITGAX FMNL2 NF2 PTPRO PLEC ANK3 FERMT1 GRIN2A GRIN2B CSNK1D TENM1 CD81 | 6.58e-04 | 599 | 211 | 16 | GO:0050839 |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 6.73e-04 | 180 | 211 | 8 | GO:0004866 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 7.09e-04 | 17 | 211 | 3 | GO:0004970 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 8.64e-04 | 187 | 211 | 8 | GO:0030414 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase inhibitor activity | 8.75e-04 | 105 | 211 | 6 | GO:0004867 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.06e-03 | 193 | 211 | 8 | GO:0015276 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 1.08e-03 | 43 | 211 | 4 | GO:0005231 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase inhibitor activity | 1.08e-03 | 43 | 211 | 4 | GO:0004869 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.21e-03 | 197 | 211 | 8 | GO:0022834 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.34e-03 | 77 | 211 | 5 | GO:0005230 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 1.37e-03 | 201 | 211 | 8 | GO:0061135 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | RAB19 VWA8 ABCA12 LRRK2 NAIP DDX11 ATP8A1 DQX1 ATP13A3 ABCC2 RAB29 RAC2 DNAH3 ATP13A1 SAR1A KIF20B SAR1B RASEF DHX32 | 1.51e-03 | 839 | 211 | 19 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | RAB19 VWA8 ABCA12 LRRK2 NAIP DDX11 ATP8A1 DQX1 ATP13A3 ABCC2 RAB29 RAC2 DNAH3 ATP13A1 SAR1A KIF20B SAR1B RASEF DHX32 | 1.53e-03 | 840 | 211 | 19 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | RAB19 VWA8 ABCA12 LRRK2 NAIP DDX11 ATP8A1 DQX1 ATP13A3 ABCC2 RAB29 RAC2 DNAH3 ATP13A1 SAR1A KIF20B SAR1B RASEF DHX32 | 1.53e-03 | 840 | 211 | 19 | GO:0016818 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.60e-03 | 118 | 211 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | LRRK2 NEK9 PASK TP53RK CDC42BPA MAP4K3 LRRK1 CSNK1D CSNK1E STK40 MAPK13 | 1.73e-03 | 363 | 211 | 11 | GO:0106310 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.77e-03 | 49 | 211 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | actin binding | MYO5A MYO6 SPTBN2 LRRK2 FMNL2 MYO5C NF2 SYNE2 PLEC FERMT1 FMNL3 WASH3P SNTB1 | 1.82e-03 | 479 | 211 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 2.00e-03 | 24 | 211 | 3 | GO:0099507 | |
| GeneOntologyMolecularFunction | virus receptor activity | 2.08e-03 | 85 | 211 | 5 | GO:0001618 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 2.19e-03 | 86 | 211 | 5 | GO:0140272 | |
| GeneOntologyMolecularFunction | apolipoprotein receptor binding | 2.25e-03 | 7 | 211 | 2 | GO:0034190 | |
| GeneOntologyMolecularFunction | extracellularly glutamate-gated ion channel activity | 2.25e-03 | 7 | 211 | 2 | GO:0005234 | |
| GeneOntologyBiologicalProcess | intracellular transport | RAB19 ZMPSTE24 MYO5A ZFYVE16 MYO6 ABCA12 USP9X PPP1R12A COPB2 LRRK2 NAPA FYCO1 B3GAT3 MYO5C SNX30 YIF1A NF2 SYNE2 RAB29 RANBP2 CDC42BPA ANK3 COPA FERMT1 VPS54 SAR1A KIF20B WASH3P TBC1D10B CSNK1D SAR1B TTC21B TENM1 NUP133 CD81 C9orf72 | 1.16e-06 | 1496 | 210 | 36 | GO:0046907 |
| GeneOntologyBiologicalProcess | Golgi vesicle transport | MYO5A COPB2 LRRK2 NAPA YIF1A RAB29 ANK3 COPA NBEA VPS54 BLZF1 SAR1A NBAS CSNK1D SAR1B | 2.20e-06 | 339 | 210 | 15 | GO:0048193 |
| GeneOntologyBiologicalProcess | actin filament organization | MYO5A MYO6 SPTBN2 BBS4 MYO5C GJA1 ACTL8 NF2 PLEC RAC2 ARAP1 GPR65 CAPN1 CYRIB FAM171A1 WASH3P TENM1 C9orf72 | 5.04e-06 | 509 | 210 | 18 | GO:0007015 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | KNTC1 MYO5A SPTBN2 LRRK2 BBS4 FYCO1 LRRTM1 NCAPG2 DDX11 GJA1 SNX30 FZR1 NF2 SYNE2 CAMSAP2 ARAP1 KNL1 GPR65 PDCD6IP CAPN1 SIVA1 SAR1A KIF20B CYRIB TFRC WASH3P TBC1D10B KATNBL1 TRIM32 SAR1B TENM1 C9orf72 | 5.99e-06 | 1342 | 210 | 32 | GO:0033043 |
| GeneOntologyBiologicalProcess | actin filament-based process | MYO5A MYO6 SPTBN2 BBS4 FMNL2 MYO5C GJA1 ACTL8 NF2 SYNE2 PLEC RAC2 ARAP1 CDC42BPA GPR65 ANK2 PDCD6IP CAPN1 CYRIB FMNL3 FAM171A1 WASH3P TRIM32 TENM1 C9orf72 | 6.82e-06 | 912 | 210 | 25 | GO:0030029 |
| GeneOntologyBiologicalProcess | intracellular protein transport | RAB19 MYO5A ZFYVE16 MYO6 ABCA12 USP9X COPB2 LRRK2 NAPA B3GAT3 RAB29 RANBP2 COPA FERMT1 VPS54 SAR1A KIF20B WASH3P SAR1B TENM1 NUP133 CD81 | 7.21e-06 | 740 | 210 | 22 | GO:0006886 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MYO5A MYO6 SPTBN2 BBS4 FMNL2 MYO5C GJA1 ACTL8 NF2 PLEC RAC2 ARAP1 CDC42BPA GPR65 PDCD6IP CAPN1 CYRIB FMNL3 FAM171A1 WASH3P TRIM32 TENM1 C9orf72 | 8.09e-06 | 803 | 210 | 23 | GO:0030036 |
| GeneOntologyBiologicalProcess | regulation of intracellular transport | ABCA12 PPP1R12A LRRK2 B3GAT3 NF2 RAB29 FERMT1 SAR1A KIF20B SAR1B TTC21B TENM1 CD81 | 2.14e-05 | 314 | 210 | 13 | GO:0032386 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | DAB2IP USP9X SPTBN2 LRRK2 NAPA BBS4 LRRTM1 GJA1 SNX30 NF2 DNAJA4 SYNE2 CAMSAP2 RAC2 ARAP1 GPR65 PDCD6IP CAPN1 FERMT1 SAR1A CYRIB TFRC WASH3P TBC1D10B TRIM32 SAR1B TENM1 C9orf72 | 3.05e-05 | 1189 | 210 | 28 | GO:0044087 |
| GeneOntologyBiologicalProcess | positive regulation of intracellular transport | 4.36e-05 | 162 | 210 | 9 | GO:0032388 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | MYO5A MYO6 USP9X SPTBN2 BBS4 PFDN4 MYO5C GJA1 ACTL8 NF2 PLEC CAMSAP2 RAC2 ARAP1 GPR65 CAPN1 CYRIB FAM171A1 WASH3P KATNBL1 CSNK1D TENM1 LUM C9orf72 | 4.44e-05 | 957 | 210 | 24 | GO:0097435 |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 6.32e-05 | 132 | 210 | 8 | GO:0035249 | |
| GeneOntologyBiologicalProcess | organelle assembly | KNTC1 RAB19 USP9X SPTBN2 LRRK2 BBS4 POGZ LRRTM1 DDB1 SNX30 ACTL8 NF2 SYNE2 PKHD1 PLEC RAB29 KNL1 PDCD6IP DNAAF4 WASH3P TBC1D10B TRIM32 CSNK1D DNAH17 TTC21B C9orf72 | 9.83e-05 | 1138 | 210 | 26 | GO:0070925 |
| GeneOntologyBiologicalProcess | cellular response to bleomycin | 1.03e-04 | 2 | 210 | 2 | GO:1904976 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | MYO5A ABCA12 ITGAM B3GAT3 GJA1 NF2 RAB29 RAC2 ANK3 GRIN2A SAR1A KIF20B TFRC WASH3P SAR1B TENM1 CD81 | 1.23e-04 | 591 | 210 | 17 | GO:1903829 |
| GeneOntologyBiologicalProcess | regulation of organelle assembly | SPTBN2 LRRK2 BBS4 LRRTM1 SNX30 NF2 SYNE2 PDCD6IP TBC1D10B TRIM32 C9orf72 | 1.47e-04 | 280 | 210 | 11 | GO:1902115 |
| GeneOntologyBiologicalProcess | actin filament-based transport | 1.62e-04 | 11 | 210 | 3 | GO:0099515 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular protein transport | 1.87e-04 | 116 | 210 | 7 | GO:0090316 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum to Golgi vesicle-mediated transport | 2.30e-04 | 159 | 210 | 8 | GO:0006888 | |
| GeneOntologyBiologicalProcess | negative regulation of hydrolase activity | DAB2IP LRRK2 NAIP BBS4 SERPINB3 SERPINB4 AHSG SERPINA7 SPINK8 APOA2 SERPINB2 | 2.52e-04 | 298 | 210 | 11 | GO:0051346 |
| GeneOntologyBiologicalProcess | regulation of cellular localization | MYO5A ABCA12 PPP1R12A LRRK2 ITGAM B3GAT3 GJA1 NF2 BYSL RAB29 RAC2 ANK3 FERMT1 NBEA GRIN2A SAR1A KIF20B TFRC WASH3P P2RX3 CSNK1E SAR1B TTC21B TENM1 CD81 C9orf72 | 2.66e-04 | 1212 | 210 | 26 | GO:0060341 |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | SPTBN2 BBS4 GJA1 NF2 ARAP1 GPR65 CAPN1 CYRIB WASH3P TENM1 C9orf72 | 2.67e-04 | 300 | 210 | 11 | GO:0110053 |
| GeneOntologyBiologicalProcess | positive regulation of transport | CYP2J2 ABCA12 LRRK2 ITGAM B3GAT3 GJA1 ATP8A1 NF2 AHSG C2 RAB29 ANK2 PDCD6IP ANK3 SIVA1 APOA2 GRIN2B SAR1A KIF20B WASH3P P2RX3 SAR1B TENM1 CD81 | 2.83e-04 | 1081 | 210 | 24 | GO:0051050 |
| GeneOntologyBiologicalProcess | cortical cytoskeleton organization | 2.84e-04 | 57 | 210 | 5 | GO:0030865 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process | DAB2IP USP9X LRRK2 DDB1 GJA1 FZR1 RAD23B DNAAF4 GRIN2A TRIM32 CSNK1D CSNK1E CD81 | 2.90e-04 | 407 | 210 | 13 | GO:0042176 |
| GeneOntologyBiologicalProcess | protein localization to organelle | KNTC1 ZFYVE16 USP9X LRRK2 BBS4 GJA1 NF2 BYSL RAB29 RAC2 KNL1 RANBP2 ANK2 FERMT1 NBEA VPS54 GRIN2A KIF20B TFRC WASH3P CSNK1D TTC21B NUP133 CD81 | 3.23e-04 | 1091 | 210 | 24 | GO:0033365 |
| GeneOntologyCellularComponent | vacuole | MYO5A MYO6 LRRK2 FYCO1 TM6SF1 GGH ATP8A1 SERPINB3 RAB29 ANK2 ANK3 RUBCNL CAPN1 ANXA11 GRIN2B SAR1A FRK WASH3P TRIM32 SBF2 SAR1B LUM C9orf72 ENPEP | 1.98e-05 | 913 | 212 | 24 | GO:0005773 |
| GeneOntologyCellularComponent | NMDA selective glutamate receptor complex | 8.26e-05 | 9 | 212 | 3 | GO:0017146 | |
| GeneOntologyCellularComponent | autophagosome | 2.14e-04 | 119 | 212 | 7 | GO:0005776 | |
| GeneOntologyCellularComponent | lamellar body membrane | 6.06e-04 | 4 | 212 | 2 | GO:0097232 | |
| GeneOntologyCellularComponent | lysosome | MYO5A MYO6 LRRK2 FYCO1 TM6SF1 GGH ATP8A1 SERPINB3 ANK2 ANK3 CAPN1 ANXA11 GRIN2B SAR1A FRK SAR1B LUM C9orf72 ENPEP | 6.30e-04 | 811 | 212 | 19 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | MYO5A MYO6 LRRK2 FYCO1 TM6SF1 GGH ATP8A1 SERPINB3 ANK2 ANK3 CAPN1 ANXA11 GRIN2B SAR1A FRK SAR1B LUM C9orf72 ENPEP | 6.30e-04 | 811 | 212 | 19 | GO:0000323 |
| GeneOntologyCellularComponent | postsynapse | MYO5A MYO6 USP9X SPTBN2 LRRK2 NAPA LRRTM1 ZZEF1 CHRNB3 PTPRO USP48 KCNT1 ANK2 ANK3 PSD3 NBEA GRIN2A GRIN2B GRIN2D TFRC P2RX3 C9orf72 | 6.98e-04 | 1018 | 212 | 22 | GO:0098794 |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 8.51e-04 | 42 | 212 | 4 | GO:0070971 | |
| GeneOntologyCellularComponent | growth cone | 9.23e-04 | 245 | 212 | 9 | GO:0030426 | |
| GeneOntologyCellularComponent | vesicle membrane | ZMPSTE24 ZFYVE16 MYO6 ABCA12 TMC6 COPB2 LRRK2 TMEM63B ITGAM ITGAX GJA1 SNX30 ATP8A1 ATP13A3 RAC2 COPA ANXA11 GRIN2A GRIN2B SAR1A TFRC WASH3P SLC30A5 SBF2 SAR1B CXCR1 | 9.56e-04 | 1325 | 212 | 26 | GO:0012506 |
| GeneOntologyCellularComponent | melanosome | 1.04e-03 | 113 | 212 | 6 | GO:0042470 | |
| GeneOntologyCellularComponent | pigment granule | 1.04e-03 | 113 | 212 | 6 | GO:0048770 | |
| GeneOntologyCellularComponent | site of polarized growth | 1.16e-03 | 253 | 212 | 9 | GO:0030427 | |
| GeneOntologyCellularComponent | early endosome | ZMPSTE24 MYO5A ZFYVE16 TMEM63B GJA1 SNX30 NF2 ATP13A3 RAB29 ANK2 APOA2 TFRC WASH3P | 1.32e-03 | 481 | 212 | 13 | GO:0005769 |
| GeneOntologyCellularComponent | costamere | 1.37e-03 | 22 | 212 | 3 | GO:0043034 | |
| Domain | TPR-like_helical_dom | SAMD9 COPB2 NAPA BBS4 ST7L TRRAP TRANK1 RANBP2 DNAAF4 CTR9 TTC21B PDCD11 | 1.07e-05 | 233 | 205 | 12 | IPR011990 |
| Domain | P-loop_NTPase | RAB19 SAMD9 MYO5A MYO6 VWA8 ABCA12 LRRK2 NAIP MYO5C DDX11 MYO15B TRANK1 DQX1 ABCC2 RAB29 RAC2 DNAH3 MSH5 LRRK1 SAR1A KIF20B SAR1B RASEF DHX32 | 2.09e-05 | 848 | 205 | 24 | IPR027417 |
| Domain | Serpin_dom | 4.34e-05 | 36 | 205 | 5 | IPR023796 | |
| Domain | SERPIN | 4.97e-05 | 37 | 205 | 5 | PS00284 | |
| Domain | Serpin | 5.67e-05 | 38 | 205 | 5 | PF00079 | |
| Domain | Serpin_fam | 6.45e-05 | 39 | 205 | 5 | IPR000215 | |
| Domain | PH_dom-like | DAB2IP SPTBN2 SSRP1 NF2 ARAP1 RANBP2 CDC42BPA FERMT1 PSD3 ECT2L NBEA ARHGEF39 SBF2 PLCH1 SNTB1 | 7.65e-05 | 426 | 205 | 15 | IPR011993 |
| Domain | FG_GAP | 8.83e-05 | 22 | 205 | 4 | PS51470 | |
| Domain | - | NAPA BBS4 ST7L TRRAP TRANK1 RANBP2 DNAAF4 CTR9 TTC21B PDCD11 | 9.99e-05 | 207 | 205 | 10 | 1.25.40.10 |
| Domain | - | DAB2IP SPTBN2 SSRP1 NF2 ARAP1 RANBP2 CDC42BPA FERMT1 PSD3 ECT2L ARHGEF39 SBF2 PLCH1 SNTB1 | 1.12e-04 | 391 | 205 | 14 | 2.30.29.30 |
| Domain | COR | 1.20e-04 | 2 | 205 | 2 | IPR032171 | |
| Domain | SAR1 | 1.20e-04 | 2 | 205 | 2 | PS51422 | |
| Domain | COR | 1.20e-04 | 2 | 205 | 2 | PF16095 | |
| Domain | Coatomer_WDAD | 1.20e-04 | 2 | 205 | 2 | PF04053 | |
| Domain | Small_GTPase_SAR1 | 1.20e-04 | 2 | 205 | 2 | IPR006687 | |
| Domain | Coatomer_WD-assoc_reg | 1.20e-04 | 2 | 205 | 2 | IPR006692 | |
| Domain | FG-GAP | 1.26e-04 | 24 | 205 | 4 | PF01839 | |
| Domain | FG-GAP | 1.26e-04 | 24 | 205 | 4 | IPR013517 | |
| Domain | VWFA | 2.84e-04 | 82 | 205 | 6 | PS50234 | |
| Domain | VWA | 3.24e-04 | 84 | 205 | 6 | SM00327 | |
| Domain | NMDAR2_C | 3.57e-04 | 3 | 205 | 2 | PF10565 | |
| Domain | NMDAR2_C | 3.57e-04 | 3 | 205 | 2 | IPR018884 | |
| Domain | VWA | 3.68e-04 | 56 | 205 | 5 | PF00092 | |
| Domain | Serpin_CS | 3.98e-04 | 32 | 205 | 4 | IPR023795 | |
| Domain | - | RAB19 SAMD9 VWA8 ABCA12 LRRK2 NAIP DDX11 TRANK1 DQX1 ABCC2 RAB29 RAC2 DNAH3 MSH5 LRRK1 SAR1A SAR1B RASEF DHX32 | 5.88e-04 | 746 | 205 | 19 | 3.40.50.300 |
| Domain | Integrin_alpha_C_CS | 6.57e-04 | 16 | 205 | 3 | IPR018184 | |
| Domain | SERPIN | 7.01e-04 | 37 | 205 | 4 | SM00093 | |
| Domain | ROC_dom | 7.09e-04 | 4 | 205 | 2 | IPR020859 | |
| Domain | ROC | 7.09e-04 | 4 | 205 | 2 | PS51424 | |
| Domain | BK_channel_a | 7.09e-04 | 4 | 205 | 2 | PF03493 | |
| Domain | K_chnl_Ca-activ_BK_asu | 7.09e-04 | 4 | 205 | 2 | IPR003929 | |
| Domain | Myosin_head_motor_dom | 7.77e-04 | 38 | 205 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 7.77e-04 | 38 | 205 | 4 | PS51456 | |
| Domain | Myosin_head | 7.77e-04 | 38 | 205 | 4 | PF00063 | |
| Domain | MYSc | 7.77e-04 | 38 | 205 | 4 | SM00242 | |
| Domain | VWF_A | 7.81e-04 | 99 | 205 | 6 | IPR002035 | |
| Domain | Integrin_alpha-2 | 9.42e-04 | 18 | 205 | 3 | IPR013649 | |
| Domain | Lig_chan-Glu_bd | 9.42e-04 | 18 | 205 | 3 | PF10613 | |
| Domain | Glu/Gly-bd | 9.42e-04 | 18 | 205 | 3 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 9.42e-04 | 18 | 205 | 3 | SM00918 | |
| Domain | INTEGRIN_ALPHA | 9.42e-04 | 18 | 205 | 3 | PS00242 | |
| Domain | Iontro_rcpt | 9.42e-04 | 18 | 205 | 3 | IPR001320 | |
| Domain | Integrin_alpha2 | 9.42e-04 | 18 | 205 | 3 | PF08441 | |
| Domain | Iono_rcpt_met | 9.42e-04 | 18 | 205 | 3 | IPR001508 | |
| Domain | Integrin_alpha | 9.42e-04 | 18 | 205 | 3 | IPR000413 | |
| Domain | Lig_chan | 9.42e-04 | 18 | 205 | 3 | PF00060 | |
| Domain | PBPe | 9.42e-04 | 18 | 205 | 3 | SM00079 | |
| Domain | PH | DAB2IP SPTBN2 ARAP1 CDC42BPA FERMT1 PSD3 ARHGEF39 SBF2 PLCH1 SNTB1 | 1.03e-03 | 278 | 205 | 10 | SM00233 |
| Domain | PH_DOMAIN | DAB2IP SPTBN2 ARAP1 CDC42BPA FERMT1 PSD3 ARHGEF39 SBF2 PLCH1 SNTB1 | 1.06e-03 | 279 | 205 | 10 | PS50003 |
| Domain | PH_domain | DAB2IP SPTBN2 ARAP1 CDC42BPA FERMT1 PSD3 ARHGEF39 SBF2 PLCH1 SNTB1 | 1.09e-03 | 280 | 205 | 10 | IPR001849 |
| Domain | Int_alpha | 1.11e-03 | 19 | 205 | 3 | SM00191 | |
| Domain | Int_alpha_beta-p | 1.11e-03 | 19 | 205 | 3 | IPR013519 | |
| Domain | Myosin_S1_N | 1.17e-03 | 5 | 205 | 2 | IPR008989 | |
| Domain | P-type_TPase_V | 1.17e-03 | 5 | 205 | 2 | IPR006544 | |
| Domain | ARM-type_fold | USP9X LRRK2 USP9Y TRRAP FMNL2 NCAPG2 EFR3A FOCAD URB1 NBEA FMNL3 | 1.35e-03 | 339 | 205 | 11 | IPR016024 |
| Domain | TPR-contain_dom | 1.36e-03 | 150 | 205 | 7 | IPR013026 | |
| Domain | Quino_amine_DH_bsu | 1.72e-03 | 22 | 205 | 3 | IPR011044 | |
| Domain | - | 1.72e-03 | 22 | 205 | 3 | 1.10.1300.10 | |
| Domain | Dilute_dom | 1.75e-03 | 6 | 205 | 2 | IPR002710 | |
| Domain | DIL | 1.75e-03 | 6 | 205 | 2 | PF01843 | |
| Domain | DILUTE | 1.75e-03 | 6 | 205 | 2 | PS51126 | |
| Domain | DIL | 1.75e-03 | 6 | 205 | 2 | SM01132 | |
| Domain | ACTININ_2 | 1.96e-03 | 23 | 205 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.96e-03 | 23 | 205 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.96e-03 | 23 | 205 | 3 | IPR001589 | |
| Domain | PDEase_catalytic_dom | 1.96e-03 | 23 | 205 | 3 | IPR002073 | |
| Domain | Small_GTPase | 1.96e-03 | 160 | 205 | 7 | IPR001806 | |
| Domain | GAF | 2.43e-03 | 7 | 205 | 2 | PF01590 | |
| Domain | Small_GTP-bd_dom | 2.50e-03 | 167 | 205 | 7 | IPR005225 | |
| Domain | Integrin_dom | 2.51e-03 | 25 | 205 | 3 | IPR032695 | |
| Domain | Kinase-like_dom | LRRK2 TRRAP NEK9 PASK TP53RK CDC42BPA PDCD6IP MAP4K3 LRRK1 FRK CSNK1D CSNK1E STK40 MAPK13 | 2.72e-03 | 542 | 205 | 14 | IPR011009 |
| Domain | GST_C | 2.81e-03 | 26 | 205 | 3 | IPR004046 | |
| Domain | GST_C | 2.81e-03 | 26 | 205 | 3 | PF00043 | |
| Domain | TPR | 3.02e-03 | 129 | 205 | 6 | SM00028 | |
| Domain | GAF | 3.21e-03 | 8 | 205 | 2 | IPR003018 | |
| Domain | GAF | 3.21e-03 | 8 | 205 | 2 | SM00065 | |
| Domain | TPR_repeat | 3.52e-03 | 133 | 205 | 6 | IPR019734 | |
| Domain | Spectrin_repeat | 3.86e-03 | 29 | 205 | 3 | IPR002017 | |
| Domain | EF_HAND_2 | 4.08e-03 | 231 | 205 | 8 | PS50222 | |
| Domain | Drf_GBD | 4.10e-03 | 9 | 205 | 2 | PF06371 | |
| Domain | Drf_FH3 | 4.10e-03 | 9 | 205 | 2 | PF06367 | |
| Domain | PH_dom-spectrin-type | 4.10e-03 | 9 | 205 | 2 | IPR001605 | |
| Domain | - | 4.10e-03 | 9 | 205 | 2 | 3.30.450.40 | |
| Domain | ZU5 | 4.10e-03 | 9 | 205 | 2 | SM00218 | |
| Domain | FH3_dom | 4.10e-03 | 9 | 205 | 2 | IPR010472 | |
| Domain | GTPase-bd | 4.10e-03 | 9 | 205 | 2 | IPR010473 | |
| Domain | GAF_dom-like | 4.10e-03 | 9 | 205 | 2 | IPR029016 | |
| Domain | Drf_FH3 | 4.10e-03 | 9 | 205 | 2 | SM01139 | |
| Domain | Drf_GBD | 4.10e-03 | 9 | 205 | 2 | SM01140 | |
| Domain | EF_hand_dom | 4.19e-03 | 232 | 205 | 8 | IPR002048 | |
| Domain | PROTEIN_KINASE_ATP | LRRK2 NEK9 PASK TP53RK CDC42BPA MAP4K3 LRRK1 FRK CSNK1D CSNK1E STK40 MAPK13 | 4.90e-03 | 459 | 205 | 12 | PS00107 |
| Domain | - | 5.09e-03 | 10 | 205 | 2 | 3.40.50.880 | |
| Domain | ZU5 | 5.09e-03 | 10 | 205 | 2 | PS51145 | |
| Domain | - | 5.11e-03 | 32 | 205 | 3 | 3.40.1110.10 | |
| Domain | - | 5.11e-03 | 32 | 205 | 3 | 2.70.150.10 | |
| Domain | SPEC | 5.11e-03 | 32 | 205 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 5.11e-03 | 32 | 205 | 3 | IPR018159 | |
| Domain | WD40_repeat_dom | 5.66e-03 | 297 | 205 | 9 | IPR017986 | |
| Domain | GST_CTER | 6.07e-03 | 34 | 205 | 3 | PS50405 | |
| Domain | GBD/FH3_dom | 6.18e-03 | 11 | 205 | 2 | IPR014768 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRANSPORT_OF_CALCIUM | 1.31e-05 | 5 | 156 | 3 | M47667 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PDYN_TO_TRANSPORT_OF_CALCIUM | 2.59e-05 | 6 | 156 | 3 | M47668 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MYO5A MYO6 PPP1R12A TMC6 NAIP TMEM63B NAPA PDE10A TRRAP NEK9 ITFG1 GMPS SNX30 NF2 FAM120C AFF1 LUZP2 ARAP1 CDC42BPA PDCD6IP ANK3 CAPN1 HECTD4 VPS54 MSH5 SLC35A3 CSNK1D SBF2 TTC21B UBA6 RASEF GREB1 PRORP METTL15 CPNE7 | 1.10e-11 | 1489 | 215 | 35 | 28611215 |
| Pubmed | ZSWIM8 MYO5A USP9X SF3A1 SPTBN2 COPB2 POGZ TRRAP DDB1 GMPS URB1 SYNE2 BYSL PLEC RANBP2 SRSF4 PDCD6IP COPA CAPN1 ANXA11 NUP133 PDCD11 NNT | 2.34e-11 | 653 | 215 | 23 | 22586326 | |
| Pubmed | MYO5A MYO6 VWA8 SF3A1 SPTBN2 SSRP1 DDB1 NCAPG2 EFR3A GJA1 PASK URB1 NF2 DNAJA4 SYNE2 BYSL USP48 RAB29 CDC42BPA ANK2 ANK3 ATP13A1 PSD3 TFRC FAM171A1 NBAS CSNK1E CTR9 NUP133 UBA6 PDCD11 C9orf72 PLCH1 SNTB1 | 4.73e-11 | 1487 | 215 | 34 | 33957083 | |
| Pubmed | DAB2IP MYO5A USP9X PPP1R12A SPTBN2 FYCO1 LRRTM1 DDB1 NEK9 DNAJA4 FAM120C SYNE2 CAMSAP2 KCNT1 RANBP2 ANK2 PDCD6IP ANK3 HECTD4 NBEA GRIN2A GRIN2B GRIN2D CYRIB FAM171A1 UBA6 | 3.58e-10 | 963 | 215 | 26 | 28671696 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | KNTC1 SF3A1 PPP1R12A COPB2 TMEM63B PFDN4 POGZ DDB1 NEK9 FZR1 URB1 DNAJA4 AHSG TIMELESS PPP2R3C ARAP1 KNL1 RAD23B RANBP2 PDCD6IP COPA WDR5 TFRC NBAS CSNK1E NUP133 TGS1 | 3.57e-09 | 1155 | 215 | 27 | 20360068 |
| Pubmed | ZMPSTE24 ZFYVE16 MYO6 USP9X SF3A1 COPB2 DDB1 EFR3A GMPS RANBP2 CDC42BPA ANK2 PDCD6IP ANK3 COPA PSD3 TFRC FAM171A1 TBC1D10B UBA6 PLCH1 | 3.87e-09 | 708 | 215 | 21 | 39231216 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYO5A MYO6 COPB2 POGZ SSRP1 TRRAP DDB1 NEK9 NCAPG2 GMPS URB1 SERPINB3 SERPINB4 BYSL PLEC TP53RK RANBP2 PDCD6IP COPA MAP4K3 CAPN1 FERMT1 WDR5 KIF20B TFRC TRIM32 CTR9 NUP133 PDCD11 | 6.22e-09 | 1353 | 215 | 29 | 29467282 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DAB2IP VWA8 TMC6 FYCO1 COMTD1 ZZEF1 TRRAP CABLES1 FOCAD SNX30 FZR1 URB1 NF2 PLEC PPP2R3C ARAP1 CDC42BPA ATP13A1 ANXA11 HECTD4 LRRK1 GRIN2D TKFC SBF2 PDCD11 STK40 | 6.25e-09 | 1105 | 215 | 26 | 35748872 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | RAB19 ZMPSTE24 MYO6 LRRK2 NAPA DDB1 GGH PTPRO SERPINB3 PKHD1 AHSG RAB29 SERPINA7 CDC42BPA PDCD6IP CAPN1 ANXA11 APOA2 CYRIB FRK TKFC ARSF CD81 ENPEP | 2.32e-08 | 1016 | 215 | 24 | 19056867 |
| Pubmed | VWA8 POGZ ZZEF1 EFR3A PASK TRANK1 KCNT1 ARAP1 CDC42BPA PDCD6IP FLYWCH1 HECTD4 LRRK1 ERI2 FMNL3 CAPRIN2 PDCD11 | 4.00e-08 | 529 | 215 | 17 | 14621295 | |
| Pubmed | DAB2IP MYO5A ZFYVE16 USP9X SPTBN2 COPB2 PFDN4 EFR3A GMPS NF2 SYNE2 KNL1 RANBP2 CDC42BPA ANK3 COPA PSD3 NBEA FAM171A1 TBC1D10B CTR9 SBF2 NUP133 SNTB1 | 4.22e-08 | 1049 | 215 | 24 | 27880917 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | SF3A1 PPP1R12A TRRAP NEK9 F13A1 CABLES1 FZR1 GTF2H5 AFF1 PLEC KNL1 RAD23B CDC42BPA MAP4K3 SAR1A FRK CSNK1D CSNK1E CTR9 NUP133 MAPK13 SNTB1 | 6.21e-08 | 910 | 215 | 22 | 36736316 |
| Pubmed | Ubiquitin-Activated Interaction Traps (UBAITs) identify E3 ligase binding partners. | 1.15e-07 | 62 | 215 | 7 | 26508657 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | ZMPSTE24 MYO5A MYO6 PPP1R12A COPB2 SSRP1 DDB1 MYO5C PLEC COPA ATP13A1 TFRC | 1.28e-07 | 268 | 215 | 12 | 33024031 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | SF3A1 COPB2 DDB1 GMPS MYO15B FAM120C PLEC USP48 ARAP1 KNL1 RANBP2 SRSF4 PDCD6IP COPA ANXA11 FERMT1 WDR5 | 1.56e-07 | 582 | 215 | 17 | 20467437 |
| Pubmed | 1.75e-07 | 9 | 215 | 4 | 17526495 | ||
| Pubmed | 2.33e-07 | 3 | 215 | 3 | 11920728 | ||
| Pubmed | Molecular and genetic determinants of the NMDA receptor for superior learning and memory functions. | 2.33e-07 | 3 | 215 | 3 | 25360708 | |
| Pubmed | Climbing-fibre activation of NMDA receptors in Purkinje cells of adult mice. | 2.33e-07 | 3 | 215 | 3 | 17901118 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | MYO5A NAPA ITGAM MYO5C ITFG1 GGH ATP8A1 AHSG C2 RAC2 SERPINA7 PDCD6IP CAPN1 ANXA11 APOA2 GSTT2B GSTT2 FRK TKFC CD81 LUM ENPEP CPNE7 | 2.48e-07 | 1070 | 215 | 23 | 23533145 |
| Pubmed | MYO5A MYO6 PPP1R12A SPTBN2 GJA1 ANK2 ANK3 PSD3 TBC1D10B CD81 NNT | 2.55e-07 | 233 | 215 | 11 | 29518331 | |
| Pubmed | SPTBN2 EFR3A GJA1 YIF1A NF2 SFT2D1 CDC42BPA MAP4K3 PRXL2A VPS54 BLZF1 SAR1A TFRC SLC30A5 PLCH1 | 2.59e-07 | 467 | 215 | 15 | 30194290 | |
| Pubmed | MYO5A MYO6 USP9X PPP1R12A SPTBN2 COPB2 LRRTM1 FMNL2 DDB1 GJA1 ATP8A1 FAM120C PLEC CAMSAP2 ANK2 PDCD6IP ANK3 COPA MAP4K3 PSD3 NBEA GRIN2A GRIN2B CYRIB P2RX3 CSNK1D PLCH1 | 2.81e-07 | 1431 | 215 | 27 | 37142655 | |
| Pubmed | DAB2IP ZMPSTE24 PPP1R12A COPB2 BBS4 ITGA9 PGGT1B F13A1 URB1 NF2 AFF1 TIMELESS PLEC BICC1 PDCD6IP ANK3 FLYWCH1 MAP4K3 MSH5 CSNK1E CTR9 SBF2 TGS1 | 3.11e-07 | 1084 | 215 | 23 | 11544199 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | KNTC1 USP9X SF3A1 PPP1R12A COPB2 PFDN4 SSRP1 ZZEF1 DDB1 NEK9 PGGT1B GMPS GGH BYSL TIMELESS PLEC TP53RK USP48 RAD23B PDCD6IP COPA EEF1E1 CAPN1 TKFC CTR9 NUP133 UBA6 | 3.89e-07 | 1455 | 215 | 27 | 22863883 |
| Pubmed | ZMPSTE24 MYO6 GMPS GPR180 GJA1 YIF1A ATP8A1 RAB29 RAC2 SRSF4 COPA ATP13A1 PRXL2A BLZF1 SAR1A TFRC SLC30A5 CSNK1E SAR1B NUP133 NNT | 5.62e-07 | 952 | 215 | 21 | 38569033 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | DAB2IP ZSWIM8 USP9X COPB2 FYCO1 POGZ SSRP1 NEK9 PASK DNAJA4 BYSL CAMSAP2 COPA FERMT1 WDR5 MSH5 BLZF1 CSNK1D CSNK1E CTR9 SBF2 TGS1 | 5.81e-07 | 1038 | 215 | 22 | 26673895 |
| Pubmed | DAB2IP MYO5A VWA8 USP9X COPB2 GMPS FAM120C PLEC CAMSAP2 RANBP2 CDC42BPA ANK2 PDCD6IP ANK3 ATP13A1 EEF1E1 PSD3 NBEA WDR5 GRIN2A GRIN2B CSNK1E TENM1 | 7.29e-07 | 1139 | 215 | 23 | 36417873 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | ZMPSTE24 USP9X NAPA NEK9 NCAPG2 B3GAT3 FOCAD GGH GJA1 PASK TIMELESS ATP13A3 CAMSAP2 BICC1 RAD23B ATP13A1 PRXL2A CYRIB TKFC SLC30A5 ZDHHC9 CD81 | 8.35e-07 | 1061 | 215 | 22 | 33845483 |
| Pubmed | MYO5A MYO6 PPP1R12A FMNL2 DDB1 EFR3A NF2 BYSL PLEC RANBP2 SRSF4 COPA WDR5 TFRC CTR9 NUP133 NHEJ1 | 8.90e-07 | 660 | 215 | 17 | 32780723 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KNTC1 MYO6 USP9X SF3A1 COPB2 POGZ SSRP1 DDB1 NEK9 URB1 SERPINB3 BYSL RAD23B RANBP2 PDCD6IP COPA ATP13A1 WDR5 SAR1A TFRC CSNK1E CTR9 NUP133 UBA6 PDCD11 NNT | 8.92e-07 | 1425 | 215 | 26 | 30948266 |
| Pubmed | 9.28e-07 | 4 | 215 | 3 | 10846184 | ||
| Pubmed | 9.28e-07 | 4 | 215 | 3 | 23892010 | ||
| Pubmed | 9.28e-07 | 4 | 215 | 3 | 12191494 | ||
| Pubmed | 9.28e-07 | 4 | 215 | 3 | 8699248 | ||
| Pubmed | 9.28e-07 | 4 | 215 | 3 | 9768843 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MYO5A MYO6 VWA8 FYCO1 DDB1 NEK9 B3GAT3 GGH YIF1A URB1 ATP13A3 RAD23B ATP13A1 CAPN1 TFRC TRIM32 NNT TGS1 | 1.24e-06 | 754 | 215 | 18 | 33060197 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | DAB2IP MYO5A USP9X SPTBN2 GJA1 ANK2 ANK3 NBEA GRIN2A GRIN2B GRIN2D | 1.61e-06 | 281 | 215 | 11 | 28706196 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MYO5A USP9X SF3A1 SPTBN2 SSRP1 TRRAP DDB1 MYO5C URB1 SYNE2 PLEC RANBP2 PDCD6IP COPA ANXA11 SAR1A TFRC NUP133 UBA6 PDCD11 NNT | 1.79e-06 | 1024 | 215 | 21 | 24711643 |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 1.91e-06 | 179 | 215 | 9 | 36261009 | |
| Pubmed | 2.31e-06 | 5 | 215 | 3 | 9147327 | ||
| Pubmed | 2.31e-06 | 5 | 215 | 3 | 21945132 | ||
| Pubmed | 2.31e-06 | 5 | 215 | 3 | 11488959 | ||
| Pubmed | Differential distributions of the NMDA receptor channel subunit mRNAs in the mouse retina. | 2.31e-06 | 5 | 215 | 3 | 7510577 | |
| Pubmed | 2.31e-06 | 5 | 215 | 3 | 16190898 | ||
| Pubmed | 2.31e-06 | 5 | 215 | 3 | 7929904 | ||
| Pubmed | 2.31e-06 | 5 | 215 | 3 | 26919761 | ||
| Pubmed | Distinct distributions of five NMDA receptor channel subunit mRNAs in the brainstem. | 2.31e-06 | 5 | 215 | 3 | 7518475 | |
| Pubmed | Distinct spatiotemporal expressions of five NMDA receptor channel subunit mRNAs in the cerebellum. | 2.31e-06 | 5 | 215 | 3 | 7518474 | |
| Pubmed | 2.31e-06 | 5 | 215 | 3 | 8015722 | ||
| Pubmed | 2.31e-06 | 5 | 215 | 3 | 15003177 | ||
| Pubmed | 2.31e-06 | 5 | 215 | 3 | 7723623 | ||
| Pubmed | 2.31e-06 | 5 | 215 | 3 | 12082569 | ||
| Pubmed | Developmental changes in distribution of NMDA receptor channel subunit mRNAs. | 2.31e-06 | 5 | 215 | 3 | 1493227 | |
| Pubmed | 2.31e-06 | 5 | 215 | 3 | 8036251 | ||
| Pubmed | NMDA receptor activation by HIV-Tat protein is clade dependent. | 2.31e-06 | 5 | 215 | 3 | 19020013 | |
| Pubmed | 2.31e-06 | 5 | 215 | 3 | 26875626 | ||
| Pubmed | 2.31e-06 | 5 | 215 | 3 | 33158444 | ||
| Pubmed | 2.31e-06 | 5 | 215 | 3 | 8756432 | ||
| Pubmed | 2.31e-06 | 5 | 215 | 3 | 18233995 | ||
| Pubmed | 2.44e-06 | 16 | 215 | 4 | 29045831 | ||
| Pubmed | DAB2IP NAPA CABLES1 NF2 ANK3 MAP4K3 PSD3 BLZF1 FAM171A1 TBC1D10B SLC30A5 PLCH1 SNTB1 | 2.55e-06 | 421 | 215 | 13 | 36976175 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | DAB2IP SPTBN2 FMNL2 EFR3A NF2 ATP13A3 ABCC2 CDC42BPA ANK2 FERMT1 PSD3 TFRC TBC1D10B MAPK13 SNTB1 | 3.01e-06 | 569 | 215 | 15 | 30639242 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | MYO6 USP9X PPP1R12A SPTBN2 USP9Y TRRAP DDB1 CABLES1 TRANK1 DPYD ANK3 NBEA APOA2 UBA6 | 3.04e-06 | 497 | 215 | 14 | 36774506 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | ZFYVE16 COPB2 PFDN4 DDB1 NCAPG2 GMPS PASK PTPRO RAD23B RANBP2 SRSF4 PDCD6IP TFRC TRIM32 CSNK1D CSNK1E CTR9 NUP133 PRORP SNTB1 | 3.13e-06 | 974 | 215 | 20 | 28675297 |
| Pubmed | ZMPSTE24 MYO5A MYO6 USP9X NAPA FYCO1 ITGAX NCAPG2 B3GAT3 ATP8A1 NF2 BYSL ATP13A3 RANBP2 PDCD6IP COPA ATP13A1 ANXA11 NBAS NUP133 CD81 NNT | 3.96e-06 | 1168 | 215 | 22 | 19946888 | |
| Pubmed | Gene structure and chromosomal localization of the mouse NMDA receptor channel subunits. | 4.06e-06 | 18 | 215 | 4 | 9011744 | |
| Pubmed | 4.60e-06 | 6 | 215 | 3 | 23665428 | ||
| Pubmed | 4.60e-06 | 6 | 215 | 3 | 8996814 | ||
| Pubmed | Cortical consequences of HIV-1 Tat exposure in rats are enhanced by chronic cocaine. | 4.60e-06 | 6 | 215 | 3 | 25760043 | |
| Pubmed | Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders. | 4.60e-06 | 6 | 215 | 3 | 12692552 | |
| Pubmed | Phosphodiesterase 10A Is Tethered to a Synaptic Signaling Complex in Striatum. | 4.60e-06 | 6 | 215 | 3 | 25762721 | |
| Pubmed | Importance of the intracellular domain of NR2 subunits for NMDA receptor function in vivo. | 4.60e-06 | 6 | 215 | 3 | 9458051 | |
| Pubmed | 4.60e-06 | 6 | 215 | 3 | 15317856 | ||
| Pubmed | In vivo assembly of the axon initial segment in motor neurons. | 4.60e-06 | 6 | 215 | 3 | 23728480 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | USP9X SF3A1 COPB2 NAPA SSRP1 ITGAM DDB1 GMPS SERPINB3 SYNE2 TP53RK KNL1 RAD23B RANBP2 PDCD6IP COPA CAPN1 ANXA11 CYRIB TFRC TRIM32 UBA6 PDCD11 NNT | 4.65e-06 | 1367 | 215 | 24 | 32687490 |
| Pubmed | ZFYVE16 MYO6 ZZEF1 FMNL2 DDB1 AFF1 PLEC SDK1 KNL1 PDCD6IP ANK3 FMNL3 CTR9 UBA6 MAPK13 | 4.75e-06 | 591 | 215 | 15 | 15231748 | |
| Pubmed | MYO5A SF3A1 PPP1R12A COPB2 DDB1 SERPINB3 BYSL PLEC ARAP1 CDC42BPA SRSF4 COPA EEF1E1 ECT2L NBEA ARHGEF39 TRIM32 CSNK1D CSNK1E | 4.83e-06 | 916 | 215 | 19 | 32203420 | |
| Pubmed | RAB19 MYO6 VWA8 SF3A1 SPTBN2 NAPA POGZ SSRP1 FMNL2 DDB1 APOBEC3F FAM120C PLEC RAD23B CDC42BPA ANK2 COPA ATP13A1 WDR5 TBC1D10B TKFC CSNK1D PDCD11 CPNE7 | 4.89e-06 | 1371 | 215 | 24 | 36244648 | |
| Pubmed | ZSWIM8 MYO5A MYO6 USP9X SPTBN2 NAPA POGZ USP9Y FMNL2 FOCAD NF2 PLEC RAD23B ANK2 ANK3 COPA ATP13A1 HECTD4 NBEA VPS54 GRIN2B TRIM32 CTR9 | 5.45e-06 | 1285 | 215 | 23 | 35914814 | |
| Pubmed | USP9X PPP1R12A COPB2 NEK9 GGH TIMELESS SERPINA7 FMNL3 TKFC SERPINB2 NNT | 6.48e-06 | 325 | 215 | 11 | 36168628 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | MYO6 USP9X COPB2 NCAPG2 B3GAT3 GPR180 GJA1 YIF1A URB1 BYSL TIMELESS RANBP2 PDCD6IP COPA ATP13A1 TFRC TBC1D10B TRIM32 NUP133 | 7.18e-06 | 942 | 215 | 19 | 31073040 |
| Pubmed | HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons. | 8.01e-06 | 7 | 215 | 3 | 11606043 | |
| Pubmed | 8.01e-06 | 7 | 215 | 3 | 12775422 | ||
| Pubmed | 8.01e-06 | 7 | 215 | 3 | 12103442 | ||
| Pubmed | 8.01e-06 | 7 | 215 | 3 | 23267846 | ||
| Pubmed | 8.01e-06 | 7 | 215 | 3 | 19036954 | ||
| Pubmed | 8.01e-06 | 7 | 215 | 3 | 10197777 | ||
| Pubmed | 8.01e-06 | 7 | 215 | 3 | 12414113 | ||
| Pubmed | 8.01e-06 | 7 | 215 | 3 | 14644469 | ||
| Pubmed | Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. | 8.01e-06 | 7 | 215 | 3 | 7569905 | |
| Pubmed | HIV immune complexes prevent excitotoxicity by interaction with NMDA receptors. | 8.01e-06 | 7 | 215 | 3 | 22940423 | |
| Pubmed | HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity. | 8.01e-06 | 7 | 215 | 3 | 11483648 | |
| Pubmed | 8.01e-06 | 7 | 215 | 3 | 22833210 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MYO5A MYO6 USP9X SF3A1 PPP1R12A SPTBN2 COPB2 SSRP1 DDB1 NEK9 GMPS PLEC RAD23B RANBP2 SRSF4 PDCD6IP ANK3 COPA EEF1E1 WDR5 TFRC | 1.04e-05 | 1149 | 215 | 21 | 35446349 |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 1.10e-05 | 344 | 215 | 11 | 30333137 | |
| Pubmed | 1.28e-05 | 8 | 215 | 3 | 8563977 | ||
| Pubmed | 1.28e-05 | 8 | 215 | 3 | 7695237 | ||
| Pubmed | 1.28e-05 | 8 | 215 | 3 | 17360663 | ||
| Pubmed | 1.28e-05 | 8 | 215 | 3 | 8724036 | ||
| Interaction | ZFPL1 interactions | SPTBN2 COPB2 EFR3A GJA1 NF2 SERPINB3 SERPINB4 ATP13A3 CDC42BPA ANK3 COPA PSD3 NBEA VPS54 TFRC FAM171A1 TBC1D10B SLC30A5 CD81 PLCH1 | 4.49e-08 | 448 | 208 | 20 | int:ZFPL1 |
| Interaction | GJD3 interactions | ZMPSTE24 ZFYVE16 MYO6 SPTBN2 FMNL2 EFR3A GJA1 YIF1A SYNE2 ATP13A3 RAB29 CDC42BPA COPA ATP13A1 TFRC FAM171A1 NBAS TBC1D10B SLC30A5 SAR1B | 5.58e-08 | 454 | 208 | 20 | int:GJD3 |
| Interaction | GJA1 interactions | ZFYVE16 MYO6 USP9X EFR3A GJA1 NF2 SYNE2 ATP13A3 SDK1 RAC2 CDC42BPA ANK3 COPA PSD3 NBEA VPS54 TFRC FAM171A1 NBAS SLC30A5 CSNK1D PLCH1 | 1.77e-07 | 583 | 208 | 22 | int:GJA1 |
| Interaction | KCNA3 interactions | ZMPSTE24 ZFYVE16 MYO6 USP9X SF3A1 COPB2 LRRK2 FYCO1 DDB1 MYO5C EFR3A GMPS NF2 PKHD1 RANBP2 CDC42BPA ANK2 PDCD6IP ANK3 COPA PSD3 TFRC FAM171A1 TBC1D10B CAPRIN2 UBA6 PLCH1 | 3.46e-07 | 871 | 208 | 27 | int:KCNA3 |
| Interaction | LAMP3 interactions | KNTC1 MYO5A ZFYVE16 SPTBN2 FMNL2 NCAPG2 EFR3A GJA1 YIF1A ATP8A1 SYNE2 ATP13A3 ATP13A1 PSD3 NBEA TFRC TBC1D10B SLC30A5 METTL15 | 7.53e-07 | 486 | 208 | 19 | int:LAMP3 |
| Interaction | OCLN interactions | DAB2IP SPTBN2 COMTD1 ITFG1 EFR3A GJA1 NF2 RAC2 CDC42BPA ANK2 ANK3 MAP4K3 PSD3 NBEA FAM171A1 TBC1D10B CSNK1E SAR1B PLCH1 | 1.15e-06 | 500 | 208 | 19 | int:OCLN |
| Interaction | CAPZA2 interactions | ZMPSTE24 MYO5A MYO6 PPP1R12A SPTBN2 LRRK2 MYO5C FZR1 PLEC USP48 BICC1 ARAP1 FRK WASH3P CSNK1E UBA6 C9orf72 | 2.54e-06 | 430 | 208 | 17 | int:CAPZA2 |
| Interaction | SIRT7 interactions | ZSWIM8 MYO5A USP9X SF3A1 SPTBN2 COPB2 POGZ TRRAP DDB1 GMPS URB1 SYNE2 BYSL PLEC RANBP2 SRSF4 PDCD6IP COPA CAPN1 ANXA11 NUP133 PDCD11 NNT | 2.87e-06 | 744 | 208 | 23 | int:SIRT7 |
| Interaction | MYO18A interactions | MYO5A ZFYVE16 MYO6 PPP1R12A SPTBN2 TRRAP MYO5C PLEC USP48 RAC2 CDC42BPA WDR5 TFRC FMNL3 | 3.42e-06 | 303 | 208 | 14 | int:MYO18A |
| Interaction | MYO6 interactions | ZFYVE16 MYO6 COPB2 DDB1 MYO5C GGH GJA1 FAM120C USP48 FHIP1A RAC2 RAD23B TFRC FMNL3 FAM171A1 C9orf72 | 4.09e-06 | 398 | 208 | 16 | int:MYO6 |
| Interaction | CTNNB1 interactions | USP9X PPP1R12A LRRK2 SSRP1 TRRAP FMNL2 DDB1 ITFG1 GJA1 FZR1 NF2 SYNE2 USP48 RAC2 RANBP2 ANK2 PDCD6IP ANK3 COPA WDR5 GRIN2B GRIN2D CSNK1D CSNK1E C9orf72 PLCH1 NNT | 5.63e-06 | 1009 | 208 | 27 | int:CTNNB1 |
| Interaction | LAMTOR1 interactions | MYO5A ZFYVE16 MYO6 SPTBN2 FYCO1 FMNL2 EFR3A GJA1 SNX30 ATP8A1 ATP13A3 RAC2 CDC42BPA CAPN1 PSD3 NBEA VPS54 TFRC FAM171A1 TBC1D10B C9orf72 PLCH1 | 6.02e-06 | 722 | 208 | 22 | int:LAMTOR1 |
| Interaction | RAC2 interactions | DAB2IP ZFYVE16 MYO6 USP9X NAPA TRRAP CABLES1 EFR3A GJA1 NF2 SYNE2 ATP13A3 RAC2 CDC42BPA PSD3 TFRC FMNL3 FAM171A1 SLC30A5 CD81 PRORP | 7.07e-06 | 674 | 208 | 21 | int:RAC2 |
| Interaction | CXADR interactions | COPB2 FMNL2 EFR3A GJA1 NF2 SYNE2 RAC2 CDC42BPA PSD3 NBEA GRIN2B FAM171A1 TBC1D10B SAR1B PLCH1 | 7.21e-06 | 369 | 208 | 15 | int:CXADR |
| Interaction | RAB35 interactions | DAB2IP MYO5A SPTBN2 FMNL2 EFR3A GJA1 NF2 SYNE2 ATP13A3 RAC2 CDC42BPA ANK3 PSD3 TFRC FAM171A1 TBC1D10B SBF2 C9orf72 PLCH1 | 8.27e-06 | 573 | 208 | 19 | int:RAB35 |
| Interaction | AGAP2 interactions | DAB2IP MYO5A USP9X SPTBN2 NF2 RAC2 ANK2 ANK3 NBEA GRIN2A GRIN2B | 1.22e-05 | 210 | 208 | 11 | int:AGAP2 |
| Interaction | CDC42 interactions | MYO6 USP9X PPP1R12A SPTBN2 LRRK2 TRRAP FMNL2 NCAPG2 PGGT1B EFR3A GJA1 YIF1A NF2 SERPINB3 SYNE2 AHSG ATP13A3 RAC2 ARAP1 CDC42BPA ANK3 COPA EEF1E1 ANXA11 PSD3 GRIN2B SAR1A TFRC FMNL3 FAM171A1 SERPINB2 | 1.56e-05 | 1323 | 208 | 31 | int:CDC42 |
| Interaction | PSD3 interactions | 1.60e-05 | 78 | 208 | 7 | int:PSD3 | |
| Interaction | MARCKS interactions | SPTBN2 SSRP1 EFR3A GGH FZR1 NF2 ATP13A3 USP48 RAC2 CDC42BPA ANK2 ANK3 ATP13A1 EEF1E1 PSD3 WDR5 TFRC FAM171A1 TBC1D10B | 1.61e-05 | 601 | 208 | 19 | int:MARCKS |
| Interaction | RHOA interactions | MYO6 USP9X PPP1R12A SPTBN2 LRRK2 NAPA TRRAP FMNL2 EFR3A GJA1 YIF1A SYNE2 ATP13A3 USP48 SDK1 RAC2 CDC42BPA ANK3 ATP13A1 WDR5 TFRC FMNL3 FAM171A1 SLC30A5 PDCD11 LUM PRORP C9orf72 PLCH1 | 1.69e-05 | 1199 | 208 | 29 | int:RHOA |
| Interaction | TOP3B interactions | DAB2IP MYO6 VWA8 SPTBN2 TMC6 FYCO1 SSRP1 COMTD1 ZZEF1 TRRAP CABLES1 FOCAD SNX30 FZR1 URB1 NF2 FAM120C BYSL AHSG PLEC PPP2R3C ARAP1 CDC42BPA PDCD6IP ATP13A1 ANXA11 HECTD4 LRRK1 GRIN2D TKFC SBF2 PDCD11 STK40 | 1.92e-05 | 1470 | 208 | 33 | int:TOP3B |
| Interaction | LAMP2 interactions | MYO5A ZFYVE16 MYO6 SPTBN2 FYCO1 EFR3A GJA1 FZR1 ATP8A1 NF2 SYNE2 ATP13A3 CDC42BPA ATP13A1 NBEA VPS54 TFRC SLC30A5 C9orf72 | 1.94e-05 | 609 | 208 | 19 | int:LAMP2 |
| Interaction | RHOB interactions | DAB2IP ZFYVE16 MYO6 USP9X SPTBN2 FMNL2 PGGT1B CABLES1 EFR3A GJA1 NF2 ATP13A3 SDK1 CDC42BPA ANK3 PSD3 NBEA TFRC FAM171A1 TBC1D10B CD81 PLCH1 SNTB1 | 2.05e-05 | 840 | 208 | 23 | int:RHOB |
| Interaction | IFITM1 interactions | ZFYVE16 MYO6 SPTBN2 NAPA FYCO1 TRRAP AHSG PDCD6IP NBEA SAR1A TFRC WASH3P CD81 C9orf72 | 2.05e-05 | 355 | 208 | 14 | int:IFITM1 |
| Interaction | C11orf52 interactions | DAB2IP SPTBN2 EFR3A NF2 ATP13A3 CDC42BPA ANK3 PSD3 LRRK1 TFRC FAM171A1 TBC1D10B PLCH1 | 2.23e-05 | 311 | 208 | 13 | int:C11orf52 |
| Interaction | TOMM70 interactions | 3.09e-05 | 153 | 208 | 9 | int:TOMM70 | |
| Interaction | NUP155 interactions | GJA1 FZR1 YIF1A FAM120C SYNE2 RAC2 PDCD6IP COPA ATP13A1 WDR5 SAR1A NBAS SLC30A5 CSNK1E NUP133 C9orf72 | 3.82e-05 | 477 | 208 | 16 | int:NUP155 |
| Interaction | DNAJC5 interactions | MYO5A MYO6 SPTBN2 EFR3A GJA1 NF2 DNAJA4 USP48 CDC42BPA ANK3 PSD3 TFRC FAM171A1 PLCH1 | 4.08e-05 | 378 | 208 | 14 | int:DNAJC5 |
| Interaction | RGS14 interactions | MYO5A MYO6 PPP1R12A SPTBN2 GJA1 ANK2 ANK3 PSD3 TBC1D10B CD81 NNT | 4.19e-05 | 240 | 208 | 11 | int:RGS14 |
| Interaction | CTDSPL interactions | 4.70e-05 | 92 | 208 | 7 | int:CTDSPL | |
| Interaction | TFRC interactions | ZFYVE16 MYO6 SPTBN2 NAPA ITFG1 GMPS GJA1 PTPRO SYNE2 RAC2 NBEA TFRC WASH3P CD81 POTEA C9orf72 | 5.13e-05 | 489 | 208 | 16 | int:TFRC |
| Interaction | SRRT interactions | SAMD9 SF3A1 SSRP1 DDB1 NCAPG2 FZR1 SERPINB3 SERPINB4 PRXL2A WDR5 SAR1B SERPINB2 PLCH1 | 5.58e-05 | 340 | 208 | 13 | int:SRRT |
| Interaction | RHOQ interactions | MYO5A ZFYVE16 SPTBN2 EFR3A GJA1 NF2 ATP13A3 CDC42BPA PSD3 TFRC FAM171A1 TBC1D10B SLC30A5 C9orf72 SNTB1 | 5.87e-05 | 442 | 208 | 15 | int:RHOQ |
| Interaction | SPTAN1 interactions | ZFYVE16 SPTBN2 TRRAP MYO5C GJA1 SYNE2 PLEC USP48 RAC2 ANK3 CAPN1 WDR5 GRIN2A GRIN2B GRIN2D TFRC | 6.06e-05 | 496 | 208 | 16 | int:SPTAN1 |
| Interaction | VAMP2 interactions | 7.38e-05 | 212 | 208 | 10 | int:VAMP2 | |
| Interaction | ITGB1 interactions | SF3A1 ITGA9 FMNL2 DDB1 GJA1 NF2 PTPRO PLEC RAC2 PDCD6IP FERMT1 SAR1A SAR1B CD81 | 7.49e-05 | 400 | 208 | 14 | int:ITGB1 |
| Interaction | TMED10 interactions | COPB2 ITFG1 FZR1 YIF1A PTPRO RAB29 COPA BLZF1 SLC30A5 SAR1B C9orf72 | 7.50e-05 | 256 | 208 | 11 | int:TMED10 |
| Interaction | RAB2A interactions | MYO5A SPTBN2 FMNL2 EFR3A GJA1 ATP13A3 RAC2 CDC42BPA PSD3 NBEA BLZF1 SAR1A TFRC TBC1D10B TKFC SLC30A5 PLCH1 | 8.75e-05 | 567 | 208 | 17 | int:RAB2A |
| Interaction | SYNGAP1 interactions | DAB2IP MYO5A PDE6B SPTBN2 COPB2 SYNE2 CAMSAP2 ANK2 NBEA GRIN2A GRIN2B GRIN2D | 8.77e-05 | 307 | 208 | 12 | int:SYNGAP1 |
| Interaction | LURAP1 interactions | 9.01e-05 | 137 | 208 | 8 | int:LURAP1 | |
| Interaction | ERGIC1 interactions | SPTBN2 COPB2 YIF1A SYNE2 COPA ATP13A1 WDR5 SAR1A TFRC CTR9 C9orf72 | 9.86e-05 | 264 | 208 | 11 | int:ERGIC1 |
| Interaction | MAP1LC3C interactions | 9.97e-05 | 72 | 208 | 6 | int:MAP1LC3C | |
| Interaction | RHOJ interactions | DAB2IP ZFYVE16 USP9X SPTBN2 CABLES1 EFR3A GJA1 NF2 ATP13A3 CDC42BPA PSD3 BLZF1 TFRC FAM171A1 TBC1D10B CSNK1D PRORP SNTB1 | 1.06e-04 | 633 | 208 | 18 | int:RHOJ |
| Interaction | MOAP1 interactions | 1.08e-04 | 46 | 208 | 5 | int:MOAP1 | |
| Interaction | DLGAP1 interactions | 1.09e-04 | 180 | 208 | 9 | int:DLGAP1 | |
| Interaction | FAM199X interactions | 1.18e-04 | 25 | 208 | 4 | int:FAM199X | |
| Interaction | NRAS interactions | DAB2IP SPTBN2 EFR3A GJA1 YIF1A NF2 SFT2D1 CDC42BPA MAP4K3 PSD3 PRXL2A VPS54 BLZF1 SAR1A TFRC SLC30A5 ZDHHC9 C9orf72 PLCH1 | 1.22e-04 | 699 | 208 | 19 | int:NRAS |
| Interaction | SPTBN1 interactions | MYO5A SPTBN2 TRRAP MYO5C GJA1 NF2 SYNE2 USP48 RAC2 ANK2 ANK3 CAPN1 WDR5 TFRC | 1.28e-04 | 421 | 208 | 14 | int:SPTBN1 |
| Interaction | LAMP1 interactions | MYO5A ZFYVE16 SPTBN2 TRRAP EFR3A GJA1 NF2 AHSG ATP13A3 CDC42BPA ATP13A1 FERMT1 PSD3 NBEA TFRC TBC1D10B SLC30A5 SAR1B | 1.31e-04 | 644 | 208 | 18 | int:LAMP1 |
| Interaction | GABARAP interactions | 1.34e-04 | 145 | 208 | 8 | int:GABARAP | |
| Interaction | FMNL1 interactions | 1.38e-04 | 109 | 208 | 7 | int:FMNL1 | |
| Interaction | FLNA interactions | MYO5A MYO6 PPP1R12A SPTBN2 NAPA PFDN4 DDB1 MYO5C GJA1 FZR1 PLEC RANBP2 ANK3 APOA2 WDR5 SAR1B CAPRIN2 CD81 | 1.41e-04 | 648 | 208 | 18 | int:FLNA |
| Interaction | RAB11A interactions | MYO5A ZFYVE16 LRRK2 NAPA MYO5C EFR3A SERPINB3 SERPINB4 SYNE2 AHSG ATP13A3 FHIP1A RAC2 CDC42BPA PSD3 NBEA TFRC TKFC NUP133 PDCD11 RASEF | 1.45e-04 | 830 | 208 | 21 | int:RAB11A |
| Interaction | PPM1G interactions | COPB2 PFDN4 ITGA9 TRRAP GMPS GJA1 FZR1 COPA ARHGEF39 SBF2 SAR1B C9orf72 | 1.50e-04 | 325 | 208 | 12 | int:PPM1G |
| Interaction | UBA6 interactions | 1.69e-04 | 150 | 208 | 8 | int:UBA6 | |
| Interaction | SLC31A1 interactions | 1.77e-04 | 192 | 208 | 9 | int:SLC31A1 | |
| Interaction | RPN2 interactions | ZMPSTE24 USP9X PPP1R12A TRRAP ITFG1 GGH PTPRO SYNE2 RAC2 SERPINA7 ATP13A1 PRXL2A WDR5 FMNL3 NBAS TKFC SAR1B SERPINB2 C9orf72 NNT | 1.82e-04 | 782 | 208 | 20 | int:RPN2 |
| Interaction | ISG15 interactions | ZMPSTE24 MYO5A MYO6 PPP1R12A COPB2 SSRP1 DDB1 MYO5C FAM120C PLEC RAD23B COPA ATP13A1 TFRC TKFC | 2.00e-04 | 494 | 208 | 15 | int:ISG15 |
| Interaction | VPS28 interactions | 2.14e-04 | 117 | 208 | 7 | int:VPS28 | |
| Interaction | KIF20A interactions | MYO6 VWA8 PPP1R12A SPTBN2 COPB2 SSRP1 USP9Y TRRAP DDB1 EFR3A APOBEC3F URB1 NF2 SYNE2 AFF1 PLEC RANBP2 ANK2 COPA HECTD4 LRRK1 TRIM32 CSNK1D NUP133 | 2.30e-04 | 1052 | 208 | 24 | int:KIF20A |
| Interaction | GABARAPL1 interactions | 2.31e-04 | 157 | 208 | 8 | int:GABARAPL1 | |
| Interaction | STX6 interactions | ZFYVE16 MYO6 COPB2 NAPA B3GAT3 GJA1 RAC2 CDC42BPA ANK3 NBEA VPS54 TFRC NBAS TBC1D10B | 2.44e-04 | 448 | 208 | 14 | int:STX6 |
| Interaction | RAC1 interactions | DAB2IP ZFYVE16 MYO6 USP9X SPTBN2 LRRK2 FMNL2 CABLES1 EFR3A GJA1 NF2 ATP13A3 USP48 RAC2 ARAP1 CDC42BPA ANK3 ATP13A1 ANXA11 PSD3 GRIN2B TFRC FAM171A1 TBC1D10B | 2.68e-04 | 1063 | 208 | 24 | int:RAC1 |
| Interaction | SLC25A22 interactions | 2.77e-04 | 122 | 208 | 7 | int:SLC25A22 | |
| Interaction | CRY1 interactions | 2.86e-04 | 162 | 208 | 8 | int:CRY1 | |
| Interaction | ZDHHC12 interactions | 2.91e-04 | 123 | 208 | 7 | int:ZDHHC12 | |
| Interaction | SH3GL1 interactions | 3.11e-04 | 164 | 208 | 8 | int:SH3GL1 | |
| Interaction | EBAG9 interactions | COPB2 EFR3A GJA1 CDC42BPA ANK3 COPA SAR1A TFRC FAM171A1 SLC30A5 SAR1B | 3.26e-04 | 303 | 208 | 11 | int:EBAG9 |
| Interaction | HNRNPC interactions | MYO6 SF3A1 PPP1R12A COPB2 SSRP1 ITGAM ITFG1 APOBEC3F FZR1 FAM120C CAMSAP2 RANBP2 SRSF4 COPA ECT2L WDR5 C9orf72 | 3.27e-04 | 634 | 208 | 17 | int:HNRNPC |
| Interaction | OTUD7A interactions | 3.28e-04 | 58 | 208 | 5 | int:OTUD7A | |
| Interaction | MCAM interactions | MYO6 FMNL2 CABLES1 EFR3A GJA1 NF2 RAC2 CDC42BPA ANK3 PSD3 TFRC FMNL3 TBC1D10B SNTB1 | 3.78e-04 | 468 | 208 | 14 | int:MCAM |
| Interaction | ITGB3 interactions | 3.95e-04 | 170 | 208 | 8 | int:ITGB3 | |
| Interaction | SCN3B interactions | TMEM63B ITGAM TRRAP ITFG1 YIF1A SERPINB3 SFT2D1 ATP13A1 SERPINB2 | 3.96e-04 | 214 | 208 | 9 | int:SCN3B |
| Interaction | CLEC4D interactions | 3.98e-04 | 261 | 208 | 10 | int:CLEC4D | |
| Interaction | GLUD2 interactions | 4.01e-04 | 34 | 208 | 4 | int:GLUD2 | |
| Interaction | FARSB interactions | 4.11e-04 | 171 | 208 | 8 | int:FARSB | |
| Interaction | HNRNPDL interactions | SF3A1 PPP1R12A COPB2 SSRP1 TRRAP ITFG1 FZR1 ABCC2 USP48 WDR5 C9orf72 METTL15 | 4.20e-04 | 364 | 208 | 12 | int:HNRNPDL |
| Cytoband | 18q21.3 | 1.63e-05 | 11 | 215 | 3 | 18q21.3 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 1.62e-05 | 7 | 142 | 3 | 1201 | |
| GeneFamily | Potassium sodium-activated channel subfamily T | 6.13e-05 | 2 | 142 | 2 | 856 | |
| GeneFamily | Myosins, class V | 1.83e-04 | 3 | 142 | 2 | 1100 | |
| GeneFamily | Serpin peptidase inhibitors | 1.97e-04 | 37 | 142 | 4 | 739 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.94e-04 | 115 | 142 | 6 | 769 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 3.55e-04 | 18 | 142 | 3 | 1160 | |
| GeneFamily | EF-hand domain containing|Nucleotide excision repair|Transcription and export complex 2 | 3.55e-04 | 18 | 142 | 3 | 1269 | |
| GeneFamily | Parkinson disease associated genes|ATPase orphan transporters | 6.03e-04 | 5 | 142 | 2 | 1213 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 6.84e-04 | 51 | 142 | 4 | 870 | |
| GeneFamily | EF-hand domain containing | 1.74e-03 | 219 | 142 | 7 | 863 | |
| GeneFamily | Complement system|Sushi domain containing | 2.80e-03 | 36 | 142 | 3 | 492 | |
| GeneFamily | Ankyrin repeat domain containing | 3.04e-03 | 242 | 142 | 7 | 403 | |
| Coexpression | GOZGIT_ESR1_TARGETS_DN | SAMD9 MYO5A MYO6 ABCA12 SPTBN2 TRANK1 NF2 DNAJA4 RAB29 SDK1 DPYD SRSF4 ANK3 RUBCNL PSD3 NBEA GRIN2A FRK CSNK1D GREB1 PLCH1 NNT | 5.59e-07 | 786 | 214 | 22 | M10961 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ZFYVE16 USP9X PPP1R12A ZZEF1 TRRAP EFR3A GMPS GJA1 SYNE2 AFF1 ATP13A3 CAMSAP2 RAD23B DPYD RANBP2 CDC42BPA PSD3 KIF20B FAM171A1 NBAS SLC35A3 SERPINB2 NUP133 | 6.17e-07 | 856 | 214 | 23 | M4500 |
| Coexpression | GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_4H_DN | LRRK2 BBS4 TM6SF1 ITFG1 SNX30 CAMSAP2 GPR65 MAP4K3 DNAH17 DHX32 | 5.21e-06 | 196 | 214 | 10 | M8717 |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 1.52e-05 | 176 | 214 | 9 | M39223 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | MYO6 PPP1R12A PDE10A TRRAP EFR3A URB1 SYNE2 C2 USP48 CAMSAP2 CDC42BPA ANK2 MAP4K3 ANXA11 CYRIB SAR1B CAPRIN2 GREB1 TGS1 | 2.86e-05 | 790 | 214 | 19 | M12490 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | KNTC1 MYO5A MYO6 USP9X ITFG1 GGH DNAJA4 SYNE2 USP48 KNL1 CDC42BPA RUBCNL BLZF1 KIF20B SLC30A5 CAPRIN2 LUM | 3.04e-05 | 656 | 214 | 17 | M18979 |
| Coexpression | GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_UP | 3.56e-05 | 196 | 214 | 9 | M3351 | |
| Coexpression | GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP | ZSWIM8 ZMPSTE24 COPB2 FOCAD TIMELESS RAC2 RAD23B TENM1 PLCH1 | 4.01e-05 | 199 | 214 | 9 | M3474 |
| Coexpression | GSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN | 4.01e-05 | 199 | 214 | 9 | M6203 | |
| Coexpression | GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN | 4.01e-05 | 199 | 214 | 9 | M6264 | |
| Coexpression | GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN | TPMT MYO5A GGH YIF1A ATP13A3 CAMSAP2 EEF1E1 FAM171A1 KATNBL1 | 4.17e-05 | 200 | 214 | 9 | M3469 |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_DN | 4.17e-05 | 200 | 214 | 9 | M9968 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_UP | 4.17e-05 | 200 | 214 | 9 | M9807 | |
| Coexpression | GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN | 4.17e-05 | 200 | 214 | 9 | M6053 | |
| Coexpression | GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN | 4.17e-05 | 200 | 214 | 9 | M7447 | |
| Coexpression | GSE23505_IL6_IL1_IL23_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP | 4.17e-05 | 200 | 214 | 9 | M7864 | |
| Coexpression | PEREZ_TP53_TARGETS | DAB2IP MYO6 ABCA12 FYCO1 LRRTM1 PDE10A ITGA9 ITGAM URB1 DQX1 COL21A1 AHSG AFF1 ARAP1 ANK3 HECTD4 PRXL2A GSTT2 FRK ZDHHC9 RASEF GREB1 MAPK13 TGS1 | 5.07e-05 | 1201 | 214 | 24 | M4391 |
| Coexpression | GAVIN_FOXP3_TARGETS_CLUSTER_P2 | 8.04e-05 | 87 | 214 | 6 | MM724 | |
| Coexpression | RIGGINS_TAMOXIFEN_RESISTANCE_DN | 9.00e-05 | 221 | 214 | 9 | M15835 | |
| Coexpression | CUI_TCF21_TARGETS_2_UP | KNTC1 GJA1 SYNE2 TIMELESS KNL1 FLYWCH1 VPS54 GSTT2B GSTT2 KCNT2 GREB1 LUM PLCH1 | 1.02e-04 | 455 | 214 | 13 | MM1189 |
| Coexpression | HAY_BONE_MARROW_ERYTHROBLAST | SPTBN2 COPB2 SSRP1 DDB1 NCAPG2 DDX11 GMPS DNAJA4 BYSL USP48 RAD23B CDC42BPA EEF1E1 WDR5 ERI2 KIF20B RHAG TFRC NBAS KATNBL1 ARHGEF39 SAR1B CAPRIN2 TGS1 | 1.21e-04 | 1271 | 214 | 24 | M39197 |
| Coexpression | QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_EXPANSION_OF_VZV_SPECIFIC_T_CELLS_TO_PEAK_AT_1DY_NEGATIVE | 1.31e-04 | 136 | 214 | 7 | M40899 | |
| Coexpression | GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_DN | 1.37e-04 | 137 | 214 | 7 | M406 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_top-relative-expression-ranked_1000 | RAB19 MYO6 VWA8 USP9X PPP1R12A SPTBN2 MYO5C ATP8A1 NF2 PTPRO PKHD1 ATP13A3 CAMSAP2 SPINK8 PDCD6IP ANK3 ANXA11 LRRK1 TFRC GSTT2 FRK LINS1 SLC35A3 TENM1 | 9.41e-07 | 786 | 209 | 24 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000 |
| CoexpressionAtlas | kidney_e13.5_Podocyte_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 9.37e-06 | 50 | 209 | 6 | gudmap_kidney_e13.5_Podocyte_MafB_k2_500 | |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R+, Bone marrow, avg-1 | KNTC1 MYO5A CYP2J2 LRRK2 ITGAM FMNL2 NCAPG2 F13A1 SNX30 KNL1 RUBCNL KIF20B TFRC CTR9 | 5.19e-05 | 405 | 209 | 14 | GSM538343_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.62e-05 | 173 | 209 | 9 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_1000_k1 | |
| CoexpressionAtlas | kidney_e15.5_Podocyte_MafB_top-relative-expression-ranked_1000 | TPMT MYO6 PFDN4 TM6SF1 PTPRO PKHD1 ATP13A3 BICC1 SFT2D1 SPINK8 FERMT1 ERI2 CYRIB TFRC FRK KCNT2 TTC21B RASEF LUM PLCH1 ENPEP | 5.72e-05 | 814 | 209 | 21 | gudmap_kidney_e15.5_Podocyte_MafB_1000 |
| CoexpressionAtlas | kidney_e13.5_Podocyte_MafB_k-means-cluster#2_top-relative-expression-ranked_100 | 7.56e-05 | 9 | 209 | 3 | gudmap_kidney_e13.5_Podocyte_MafB_k2_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.02e-04 | 146 | 209 | 8 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | TPMT CYP2J2 MYO6 VWA8 LRRK2 PTGR2 SYNE2 PKHD1 ABCC2 BICC1 DPYD SPINK8 ANK3 DNAAF4 APOA2 GSTT2 SLC35A3 TKFC NNT ENPEP | 1.30e-04 | 799 | 209 | 20 | gudmap_kidney_adult_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2 | KNTC1 CYP2J2 ITGAM FMNL2 NCAPG2 F13A1 SNX30 SYNE2 KNL1 RUBCNL KIF20B TFRC CTR9 | 1.31e-04 | 388 | 209 | 13 | GSM538352_500 |
| CoexpressionAtlas | kidney_e13.5_Podocyte_MafB_top-relative-expression-ranked_500 | PFDN4 SST TM6SF1 AFF1 BICC1 GPR65 PSD3 KCNT2 TRIM32 RASEF LUM ENPEP | 1.51e-04 | 341 | 209 | 12 | gudmap_kidney_e13.5_Podocyte_MafB_500 |
| CoexpressionAtlas | B cells, preB.FrD.FL, AA4.1+ IgM- CD19+ CD43- CD24+, Fetal Liver, avg-3 | KNTC1 NCAPG2 F13A1 SNX30 AFF1 KNL1 KIF20B TFRC GSTT2 SLC30A5 P2RX3 NNT ENPEP | 1.57e-04 | 395 | 209 | 13 | GSM538340_500 |
| ToppCell | COVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | MYO5A NAIP ITGAX FMNL2 F13A1 DPYD CYRIB TFRC SBF2 C9orf72 SNTB1 | 3.10e-09 | 195 | 215 | 11 | c172c5599379c29123340621a36bfb1fc90c2115 |
| ToppCell | COVID-19-Myeloid|COVID-19 / group, cell type (main and fine annotations) | MYO5A ITGAM ITGAX FMNL2 F13A1 DPYD CYRIB TFRC SBF2 C9orf72 SNTB1 | 3.64e-09 | 198 | 215 | 11 | 33f0a919188a67d2a876b52c61a1cec2c9747969 |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.84e-09 | 199 | 215 | 11 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.24e-08 | 196 | 215 | 10 | 7026c1fc33425e5476063d17c79e4b79356a9e01 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.31e-07 | 179 | 215 | 9 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-07 | 179 | 215 | 9 | df4d0b2fe47d2c7def729b3217cb01ced01495ff | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.19e-07 | 186 | 215 | 9 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.49e-07 | 188 | 215 | 9 | 3be2d50148daa4eddddc2c7f269f45c97f7e4931 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.49e-07 | 188 | 215 | 9 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.99e-07 | 191 | 215 | 9 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.17e-07 | 192 | 215 | 9 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.36e-07 | 193 | 215 | 9 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.55e-07 | 194 | 215 | 9 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 4.75e-07 | 195 | 215 | 9 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.96e-07 | 196 | 215 | 9 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | COVID-19-Myeloid-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 4.96e-07 | 196 | 215 | 9 | 4929cfed1f150c1fde4d79cb49895c2ea467a18f | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 5.17e-07 | 197 | 215 | 9 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-BMP_responsible_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 5.87e-07 | 200 | 215 | 9 | 5fb90118d3abc28d72bc483e68317255090a04c7 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-06 | 164 | 215 | 8 | f3684d029ca58b782e3e87f79e56069b42b22fdd | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-06 | 164 | 215 | 8 | b1a6f56207cb0fbd3f99225d4a7354a17aa26362 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Myeloid-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-06 | 165 | 215 | 8 | 8a3cfec76cc7c5a309d582becd1aef4261b7f4e1 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 166 | 215 | 8 | cd22d4222bc748942ed570a8978cb015e3b55388 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 166 | 215 | 8 | 5f6031420bffb1813fe4989021f9f3a54a7243b0 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Myeloid-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-06 | 167 | 215 | 8 | e984278c209cc52dbb752686db772e713afab33d | |
| ToppCell | facs-Heart-LV-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-06 | 174 | 215 | 8 | 54166a0faf748cccb6406c2c268e1e6e21caf6d0 | |
| ToppCell | facs-Heart-LV-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-06 | 174 | 215 | 8 | dc8a238ec1d954bec0f8eb67c04a61734c96f5b5 | |
| ToppCell | facs-Heart-LV-3m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-06 | 175 | 215 | 8 | 5d106ef542b97f97aeb19179e3f72963ead1e82a | |
| ToppCell | droplet-Heart-HEART-1m-Hematologic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-06 | 175 | 215 | 8 | 43b9cfd7c47d57244565c641e57f3256b5900804 | |
| ToppCell | droplet-Heart-HEART-1m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-06 | 176 | 215 | 8 | 1df640f88667e2dad30e65279d6d33bba75024c1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.76e-06 | 180 | 215 | 8 | b6efdb4d319ef6f87f559acd974e5a71b06a2322 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 2.87e-06 | 181 | 215 | 8 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.24e-06 | 184 | 215 | 8 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.38e-06 | 185 | 215 | 8 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 3.38e-06 | 185 | 215 | 8 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 3.96e-06 | 189 | 215 | 8 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.28e-06 | 191 | 215 | 8 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.28e-06 | 191 | 215 | 8 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 4.28e-06 | 191 | 215 | 8 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 4.28e-06 | 191 | 215 | 8 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 4.44e-06 | 192 | 215 | 8 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.62e-06 | 193 | 215 | 8 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.62e-06 | 193 | 215 | 8 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.62e-06 | 193 | 215 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.80e-06 | 194 | 215 | 8 | 3043f6230fa723037c8cf7123f611ae847b39fd4 | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.98e-06 | 195 | 215 | 8 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | COVID-19-lung-Macrophage_metabolically_active|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.17e-06 | 196 | 215 | 8 | 1b7928f4eee94d4bb6ea410bab68a471dba12979 | |
| ToppCell | COVID-19-lung-Macrophage_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type | 5.17e-06 | 196 | 215 | 8 | a753d76d764c181eecb0e17a794a2e7d0ff70136 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.17e-06 | 196 | 215 | 8 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-06 | 197 | 215 | 8 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.57e-06 | 198 | 215 | 8 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | mild-HLA-DR-_S100A+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.78e-06 | 199 | 215 | 8 | d0d286eafe935f9b3aaba5b783e8911251121b4a | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 5.78e-06 | 199 | 215 | 8 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.78e-06 | 199 | 215 | 8 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.94e-06 | 142 | 215 | 7 | be63c48794a227ea55978524c0f5935342fc455e | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 6.00e-06 | 200 | 215 | 8 | 691b3edf7d8449556e8bf611662eb85772959f0f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells-Neuroepithelial_cell|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 6.00e-06 | 200 | 215 | 8 | 4e077aa7faddcebdfc54667f8b3990704441005b | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 6.00e-06 | 200 | 215 | 8 | f5bc7d30aa03dd0f95eb64255bd1a2543be8d327 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 6.00e-06 | 200 | 215 | 8 | 36a110aa91a791fdf1142e7869e8aa0d342402d0 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.00e-06 | 200 | 215 | 8 | c210b98a75ab5d899d7278bc9b577f76a0b3970c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Mesenchymal|10w / Sample Type, Dataset, Time_group, and Cell type. | 6.00e-06 | 200 | 215 | 8 | c968d077b7fd24fb06cedb51c737996f25667eb7 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 6.00e-06 | 200 | 215 | 8 | d17ba4239e1fd702a3d757687110f0f2c6f91ef7 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-05 | 164 | 215 | 7 | d005cfd821b87548b075120bffe65a0be9860463 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-05 | 164 | 215 | 7 | beaa13a75c3bb72446c85084d75e9fe3f15fd3d4 | |
| ToppCell | PND14-Immune-Immune_Myeloid|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.58e-05 | 165 | 215 | 7 | e37d00084f58fbd25f66ee65be510c030167084e | |
| ToppCell | facs-SCAT-Fat-3m-Myeloid-myeloid_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 166 | 215 | 7 | 8395c74db8e4e54af97a3f2b75cb75171140ec31 | |
| ToppCell | Thalamus-Hematopoietic|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.65e-05 | 166 | 215 | 7 | 76d60ac7ac5d1eaf530f0c741d9c48e0bd58396b | |
| ToppCell | facs-SCAT-Fat-3m-Myeloid|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 166 | 215 | 7 | 76807edc5620514b53a14be354b84c54c112b8f9 | |
| ToppCell | facs-SCAT-Fat-3m-Myeloid-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 166 | 215 | 7 | 645b842b94b8d2f4b26c2623f8589f56bd782c26 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.65e-05 | 166 | 215 | 7 | 49103b75c3e08656c5774f56fd00d7bd53eefcfb | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 167 | 215 | 7 | 54576e9863403d0d5e3046e61db1ad695d88fee4 | |
| ToppCell | facs-Heart-RV-3m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-05 | 168 | 215 | 7 | c1a5f4f4d32a1f8583048db709a7037cc9357ad8 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.78e-05 | 168 | 215 | 7 | c3d2d573f21350a4a674faff30b06ff644d00ac3 | |
| ToppCell | facs-Heart-RV-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-05 | 168 | 215 | 7 | 8ee57814c7e9d45444f48b6b269c4d535bc4d5e1 | |
| ToppCell | facs-Heart-RV-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-05 | 168 | 215 | 7 | a405f0de70293f68b4e000c1fc8a9ad33d56539a | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-05 | 169 | 215 | 7 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | facs-Trachea-nan-18m-Myeloid-macrophage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-05 | 169 | 215 | 7 | c6ae131f0bfb757541322691311139fae8bdca21 | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid-tracheal_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.92e-05 | 170 | 215 | 7 | e4856e768d0088e42fbdb8e6039f5bc3daa0afdb | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Uncommitted_AE_cell|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.92e-05 | 170 | 215 | 7 | 5a64e05c263df915085988d881808221e2c0f2e2 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.92e-05 | 170 | 215 | 7 | 4ce81608111b9ee7cb974dad2c182f38db3dcd79 | |
| ToppCell | droplet-Heart-nan-18m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 171 | 215 | 7 | 79b806194df645cccd357520eb6801ab1e93b3c5 | |
| ToppCell | droplet-Heart-nan-18m-Hematologic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 171 | 215 | 7 | 2594ba8236a69461d9786ffcd882c39d0c9d5788 | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.07e-05 | 172 | 215 | 7 | c260680f5455fce133b7b4158b4197fc76115779 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.15e-05 | 173 | 215 | 7 | 6d29e142d043dfd1ed442812358ac463b63b5e3f | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-tracheal_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.23e-05 | 174 | 215 | 7 | d67fc8e30cc67fff8f7fdeaccb409d12ca0992c1 | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.23e-05 | 174 | 215 | 7 | 2f25fba5225f4687df4396645e94565a640b5583 | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.31e-05 | 175 | 215 | 7 | 22fd7d9b4d403cc8061316855f78bad0eb705ce9 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-05 | 175 | 215 | 7 | a8b05972e1bec4de73feaa6c4a9bcbe6b50c8044 | |
| ToppCell | droplet-Heart-HEART-1m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 175 | 215 | 7 | a2fed97cf8d28f9936fe791e5e8c43d2430330c9 | |
| ToppCell | facs-Trachea-3m-Hematologic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.49e-05 | 177 | 215 | 7 | c9d235fc518b291ed98088a1206d14d6692bc7fd | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.49e-05 | 177 | 215 | 7 | 3e149bff1f1b393a7abe98984e37981c8296f95d | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.58e-05 | 178 | 215 | 7 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.67e-05 | 179 | 215 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.77e-05 | 180 | 215 | 7 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.87e-05 | 181 | 215 | 7 | 6873c1138b28c130637d06b64981ad11c262e85f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-05 | 182 | 215 | 7 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | cellseq2-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-NK|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.97e-05 | 182 | 215 | 7 | 8ccffcbae28c374fd4161fb0d4cf2c49fae557f6 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.97e-05 | 182 | 215 | 7 | de15a77b8d3527638bea5b04e0b2af03ac93bc18 | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.08e-05 | 183 | 215 | 7 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.08e-05 | 183 | 215 | 7 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.19e-05 | 184 | 215 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; MCF7; HT_HG-U133A | TMC6 NEK9 FZR1 NF2 DNAJA4 FAM120C ARAP1 PSD3 SIVA1 SAR1A GREB1 | 2.31e-06 | 196 | 211 | 11 | 2291_DN |
| Drug | Agmatine | 4.80e-06 | 13 | 211 | 4 | ctd:D000376 | |
| Drug | etridiazole | 6.67e-06 | 50 | 211 | 6 | CID000017432 | |
| Drug | 5-(alpha-methyl-4-bromobenzylamino)phosphonomethyl-1,4-dihydroquinoxaline-2,3-dione | 7.74e-06 | 5 | 211 | 3 | ctd:C498554 | |
| Drug | 2-Aminoadipic Acid | 7.74e-06 | 5 | 211 | 3 | ctd:D015074 | |
| Drug | (2S*,3R*)-1-(biphenyl-4-carbonyl)piperazine-2,3-dicarboxylic acid | 7.74e-06 | 5 | 211 | 3 | ctd:C491996 | |
| Drug | SDZ EAA 494 | 7.74e-06 | 5 | 211 | 3 | ctd:C065286 | |
| Drug | 1,4-bis-(phenoxyacetyl)piperazine | ZFYVE16 PDCD6IP NBEA GRIN2A GRIN2B GRIN2D SAR1A TFRC CSNK1D CSNK1E ENPEP | 8.66e-06 | 225 | 211 | 11 | CID001008511 |
| Drug | Megestrol acetate [595-33-5]; Up 200; 10.4uM; HL60; HT_HG-U133A | MYO6 ZZEF1 URB1 TRANK1 ATP8A1 FAM120C ANK2 ANK3 DNAH17 ENPEP | 1.48e-05 | 195 | 211 | 10 | 3091_UP |
| Drug | Oxymetazoline hydrochloride [2315-02-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A | ABCA12 URB1 NF2 TIMELESS CDC42BPA COPA SLC30A5 DNAH17 GREB1 PLCH1 | 1.48e-05 | 195 | 211 | 10 | 2278_DN |
| Drug | Meperidine | 1.54e-05 | 6 | 211 | 3 | DB00454 | |
| Drug | 1,5-(diethylamino)piperidine | 1.54e-05 | 6 | 211 | 3 | CID000004025 | |
| Drug | Naphthols | 1.54e-05 | 6 | 211 | 3 | ctd:D009284 | |
| Drug | S-(+)-ibuprofen [51146-56-6]; Down 200; 19.4uM; MCF7; HT_HG-U133A | 1.54e-05 | 196 | 211 | 10 | 6471_DN | |
| Drug | Lysergol [602-85-7]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.69e-05 | 198 | 211 | 10 | 3261_DN | |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; MCF7; HT_HG-U133A | ABCA12 FZR1 DNAJA4 FAM120C TIMELESS ARAP1 PSD3 TLR5 NNT CPNE7 | 1.84e-05 | 200 | 211 | 10 | 4364_DN |
| Drug | Tenocyclidine | 2.67e-05 | 7 | 211 | 3 | DB01520 | |
| Drug | tetrazol-5-yl)glycine | 2.67e-05 | 7 | 211 | 3 | CID000126383 | |
| Drug | 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid | 2.67e-05 | 7 | 211 | 3 | ctd:C050592 | |
| Drug | homoquinolinate | 2.67e-05 | 7 | 211 | 3 | CID003080554 | |
| Drug | S)-piperazine-2-carboxylic acid | 2.67e-05 | 7 | 211 | 3 | CID001502069 | |
| Drug | dimethyl pimelimidate | 3.09e-05 | 20 | 211 | 4 | CID000065403 | |
| Drug | risperidone | 4.06e-05 | 136 | 211 | 8 | CID000005073 | |
| Drug | Murametide | 4.25e-05 | 8 | 211 | 3 | CID000133276 | |
| Drug | L-687,414 | 4.25e-05 | 8 | 211 | 3 | CID000125556 | |
| Drug | 6-chloroquinoxaline-2,3-diol | 4.25e-05 | 8 | 211 | 3 | CID000081143 | |
| Drug | ES-242-1 | 4.25e-05 | 8 | 211 | 3 | CID000131976 | |
| Drug | SDZ 220-581 | 4.25e-05 | 8 | 211 | 3 | CID000128019 | |
| Drug | 3alpha5betaHS | 4.25e-05 | 8 | 211 | 3 | CID000165024 | |
| Drug | neramexane | 4.25e-05 | 8 | 211 | 3 | CID006433106 | |
| Drug | piperazine-2,3-dicarboxylic acid | 4.25e-05 | 8 | 211 | 3 | CID000280973 | |
| Drug | AC1NRBPQ | 4.28e-05 | 137 | 211 | 8 | CID005288569 | |
| Drug | phencyclidine | 5.05e-05 | 181 | 211 | 9 | CID000006468 | |
| Drug | IAHS | 6.33e-05 | 9 | 211 | 3 | CID003037832 | |
| Drug | Phenanthrenes | 6.33e-05 | 9 | 211 | 3 | ctd:D010616 | |
| Drug | AC1LD8HW | 6.98e-05 | 75 | 211 | 6 | CID000644061 | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 7.05e-05 | 189 | 211 | 9 | 1646_UP | |
| Drug | NaCN | 7.29e-05 | 47 | 211 | 5 | CID000008929 | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 7.65e-05 | 191 | 211 | 9 | 4168_DN | |
| Drug | Carbarsone [121-59-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 7.96e-05 | 192 | 211 | 9 | 4110_DN | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 8.62e-05 | 194 | 211 | 9 | 4727_DN | |
| Drug | Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; MCF7; HT_HG-U133A | 8.62e-05 | 194 | 211 | 9 | 7221_DN | |
| Drug | estradiol, USP; Down 200; 0.01uM; HL60; HT_HG-U133A | 8.96e-05 | 195 | 211 | 9 | 2701_DN | |
| Drug | Dacarbazine [4342-03-4]; Down 200; 22uM; HL60; HG-U133A | 8.96e-05 | 195 | 211 | 9 | 1762_DN | |
| Drug | Etofenamate [30544-47-9]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 8.96e-05 | 195 | 211 | 9 | 7327_DN | |
| Drug | N-vinyl-2-pyrrolidinone | 9.13e-05 | 26 | 211 | 4 | ctd:C042670 | |
| Drug | Trimipramine maleate salt [521-78-8]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 9.32e-05 | 196 | 211 | 9 | 3342_DN | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 9.69e-05 | 197 | 211 | 9 | 2259_DN | |
| Drug | Trazodone hydrochloride [25332-39-2]; Down 200; 9.8uM; HL60; HT_HG-U133A | 9.69e-05 | 197 | 211 | 9 | 2379_DN | |
| Drug | Bepridil hydrochloride [74764-40-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 9.69e-05 | 197 | 211 | 9 | 2629_DN | |
| Drug | Quipazine dimaleate salt [4774-24-7]; Down 200; 9uM; PC3; HT_HG-U133A | 9.69e-05 | 197 | 211 | 9 | 5887_DN | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Up 200; 13uM; HL60; HT_HG-U133A | 9.69e-05 | 197 | 211 | 9 | 2356_UP | |
| Drug | Colchicine [64-86-8]; Down 200; 10uM; MCF7; HT_HG-U133A | 9.69e-05 | 197 | 211 | 9 | 5675_DN | |
| Drug | Azathioprine [446-86-6]; Down 200; 14.4uM; MCF7; HT_HG-U133A | PDE6B TM6SF1 FZR1 NF2 DNAJA4 TIMELESS CDC42BPA SLC30A5 ENPEP | 1.01e-04 | 198 | 211 | 9 | 5627_DN |
| Drug | Tropine [120-29-6]; Down 200; 28.4uM; MCF7; HT_HG-U133A | 1.01e-04 | 198 | 211 | 9 | 3569_DN | |
| Drug | Metolazone [17560-51-9]; Up 200; 11uM; PC3; HT_HG-U133A | 1.01e-04 | 198 | 211 | 9 | 6292_UP | |
| Drug | Nisoxetine hydrochloride [57754-86-6]; Down 200; 13uM; HL60; HT_HG-U133A | 1.01e-04 | 198 | 211 | 9 | 3117_DN | |
| Drug | Iopamidol [60166-93-0]; Down 200; 5.2uM; PC3; HT_HG-U133A | 1.05e-04 | 199 | 211 | 9 | 5832_DN | |
| Drug | Phenelzine sulfate [156-51-4]; Down 200; 17uM; MCF7; HT_HG-U133A | 1.05e-04 | 199 | 211 | 9 | 2319_DN | |
| Drug | Merbromin [129-16-8]; Down 200; 5uM; PC3; HT_HG-U133A | 1.05e-04 | 199 | 211 | 9 | 7398_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A | 1.05e-04 | 199 | 211 | 9 | 6969_DN | |
| Drug | Proparacaine hydrochloride [5875-06-9]; Up 200; 12uM; MCF7; HT_HG-U133A | 1.05e-04 | 199 | 211 | 9 | 6492_UP | |
| Drug | Ivermectin [70288-86-7]; Up 200; 4.6uM; PC3; HT_HG-U133A | 1.05e-04 | 199 | 211 | 9 | 5853_UP | |
| Drug | Tocainide hydrochloride; Up 200; 17.4uM; HL60; HT_HG-U133A | 1.05e-04 | 199 | 211 | 9 | 2931_UP | |
| Drug | Amrinone [60719-84-8]; Down 200; 21.4uM; MCF7; HT_HG-U133A | 1.05e-04 | 199 | 211 | 9 | 6826_DN | |
| Drug | Vitexin [3681-93-4]; Up 200; 9.2uM; PC3; HT_HG-U133A | 1.09e-04 | 200 | 211 | 9 | 4588_UP | |
| Drug | Pyrimethamine [58-14-0]; Up 200; 16uM; MCF7; HT_HG-U133A | 1.09e-04 | 200 | 211 | 9 | 1474_UP | |
| Drug | B0683 | 1.11e-04 | 117 | 211 | 7 | CID006398969 | |
| Drug | EAB 515 | 1.23e-04 | 11 | 211 | 3 | CID000159489 | |
| Drug | 5-phosphonopentanoic acid | 1.23e-04 | 11 | 211 | 3 | CID002773807 | |
| Drug | CK1 inhibitor | 1.23e-04 | 11 | 211 | 3 | CID006419753 | |
| Drug | oxiracetam | 1.23e-04 | 11 | 211 | 3 | CID000004626 | |
| Drug | o-difluorobenzene | 1.23e-04 | 11 | 211 | 3 | CID000009706 | |
| Drug | donepezil | 1.30e-04 | 53 | 211 | 5 | CID000003152 | |
| Drug | MDL 28170 | 1.43e-04 | 54 | 211 | 5 | CID000072430 | |
| Drug | Air Pollutants, Occupational | SAMD9 COPB2 LRRK2 NAIP ITGAM MYO15B TRANK1 C2 ARAP1 SFT2D1 DPYD SRSF4 ANK2 CTR9 TLR5 SERPINB2 DHX32 CXCR1 | 1.52e-04 | 725 | 211 | 18 | ctd:D000395 |
| Drug | AC1L9LT0 | 1.52e-04 | 123 | 211 | 7 | CID000448294 | |
| Drug | CP-96,345 | 1.56e-04 | 55 | 211 | 5 | CID000104943 | |
| Drug | CI-1041 | 1.62e-04 | 12 | 211 | 3 | CID000156328 | |
| Drug | tenocyclidine | 1.62e-04 | 12 | 211 | 3 | CID000062751 | |
| Drug | AC1L32TU | 1.63e-04 | 30 | 211 | 4 | CID000107831 | |
| Drug | AC1L9MEA | 1.85e-04 | 31 | 211 | 4 | CID000448829 | |
| Drug | hexachlorophene | 1.92e-04 | 90 | 211 | 6 | CID000003598 | |
| Drug | HA1 100 | 1.92e-04 | 90 | 211 | 6 | CID003064778 | |
| Drug | 1,10-diaminodecane | 2.10e-04 | 13 | 211 | 3 | CID000001317 | |
| Drug | NSC-724654 | 2.10e-04 | 13 | 211 | 3 | CID009572716 | |
| Drug | D0303 | 2.10e-04 | 13 | 211 | 3 | CID009809426 | |
| Drug | remifentanil | 2.10e-04 | 32 | 211 | 4 | CID000060814 | |
| Drug | NSC-673323 | 2.10e-04 | 32 | 211 | 4 | CID000384101 | |
| Drug | cnicin | 2.17e-04 | 92 | 211 | 6 | CID000091176 | |
| Drug | AC1L1CLB | 2.17e-04 | 92 | 211 | 6 | CID000001951 | |
| Disease | epilepsy (implicated_via_orthology) | 2.17e-05 | 163 | 208 | 8 | DOID:1826 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease (biomarker_via_orthology) | 4.95e-05 | 2 | 208 | 2 | DOID:10595 (biomarker_via_orthology) | |
| Disease | Malignant neoplasm of breast | ITGA9 GPR180 GJA1 NF2 SYNE2 AFF1 TIMELESS RAC2 DPYD ANK2 GRIN2D TFRC KCNT2 CSNK1D ANKEF1 SERPINB2 TENM1 NUP133 DHX32 ENPEP | 7.99e-05 | 1074 | 208 | 20 | C0006142 |
| Disease | Colorectal Carcinoma | ABCA12 SF3A1 SPTBN2 CABLES1 GGH PKHD1 ABCC2 CAMSAP2 DPYD DNAH3 ANK2 GRIN2A ERI2 TFRC TENM1 | 1.49e-04 | 702 | 208 | 15 | C0009402 |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.96e-04 | 49 | 208 | 4 | DOID:0060037 (implicated_via_orthology) | |
| Disease | epilepsy (biomarker_via_orthology) | 4.18e-04 | 21 | 208 | 3 | DOID:1826 (biomarker_via_orthology) | |
| Disease | Progeria | 4.88e-04 | 5 | 208 | 2 | C0033300 | |
| Disease | Autistic Disorder | 5.59e-04 | 261 | 208 | 8 | C0004352 | |
| Disease | Bipolar Disorder | PDE10A SST ITGA9 ITGAM CHRNB3 TRANK1 TIMELESS ANK3 GRIN2A GRIN2B CSNK1E | 6.14e-04 | 477 | 208 | 11 | C0005586 |
| Disease | Clear cell sarcoma of kidney | 7.28e-04 | 6 | 208 | 2 | C0334488 | |
| Disease | reaction time measurement | LRRK2 EFR3A PTPRO PKHD1 DPYD ATP13A1 HECTD4 GPX7 GRIN2A GRIN2B FAM171A1 CSNK1D METTL15 | 8.52e-04 | 658 | 208 | 13 | EFO_0008393 |
| Disease | syndromic X-linked intellectual disability Najm type (implicated_via_orthology) | 1.01e-03 | 7 | 208 | 2 | DOID:0060807 (implicated_via_orthology) | |
| Disease | bipolar disorder (is_implicated_in) | 1.10e-03 | 29 | 208 | 3 | DOID:3312 (is_implicated_in) | |
| Disease | waist-hip ratio | KNTC1 BBS4 ITGA9 ZZEF1 CABLES1 SYNE2 LUZP2 KNL1 DPYD PDCD6IP ANK3 HECTD4 WDR5 GRIN2B KCNT2 SBF2 DNAH17 CAPRIN2 SNTB1 | 1.15e-03 | 1226 | 208 | 19 | EFO_0004343 |
| Disease | serum metabolite measurement | PDE10A ITGAM F13A1 DNAJA4 SYNE2 LUZP2 TP53RK ABCC2 DPYD CDC42BPA PSD3 KCNT2 SAR1B DNAH17 ENPEP SNTB1 | 1.15e-03 | 945 | 208 | 16 | EFO_0005653 |
| Disease | Liver Cirrhosis, Experimental | MYO5A ZFYVE16 TM6SF1 GGH GJA1 PTPRO ABCC2 RAC2 SERPINA7 NBEA CYRIB TKFC LUM ENPEP | 1.26e-03 | 774 | 208 | 14 | C0023893 |
| Disease | Age-related nuclear cataract | 1.34e-03 | 31 | 208 | 3 | HP_0011142 | |
| Disease | placental insufficiency (biomarker_via_orthology) | 1.35e-03 | 8 | 208 | 2 | DOID:3891 (biomarker_via_orthology) | |
| Disease | Galloway Mowat syndrome | 1.35e-03 | 8 | 208 | 2 | C0795949 | |
| Disease | cognitive disorder (biomarker_via_orthology) | 1.35e-03 | 8 | 208 | 2 | DOID:1561 (biomarker_via_orthology) | |
| Disease | phenol sulfate measurement | 1.35e-03 | 8 | 208 | 2 | EFO_0021011 | |
| Disease | hair color | 1.72e-03 | 311 | 208 | 8 | EFO_0003924 | |
| Disease | anemia (phenotype), response to ribavirin | 1.72e-03 | 9 | 208 | 2 | EFO_0004272, GO_1901559 | |
| Disease | complement factor B measurement | 1.72e-03 | 9 | 208 | 2 | EFO_0008096 | |
| Disease | Borderline personality disorder | 1.91e-03 | 35 | 208 | 3 | HP_0012076 | |
| Disease | cystic kidney disease (implicated_via_orthology) | 2.14e-03 | 10 | 208 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | Developmental delay (disorder) | 2.25e-03 | 37 | 208 | 3 | C0424605 | |
| Disease | response to vaccine, cytokine measurement | 2.41e-03 | 131 | 208 | 5 | EFO_0004645, EFO_0004873 | |
| Disease | Global developmental delay | 2.57e-03 | 133 | 208 | 5 | C0557874 | |
| Disease | Semantic-Pragmatic Disorder | 2.61e-03 | 11 | 208 | 2 | C0454655 | |
| Disease | Auditory Processing Disorder, Central | 2.61e-03 | 11 | 208 | 2 | C0751257 | |
| Disease | hyperhomocysteinemia (implicated_via_orthology) | 2.61e-03 | 11 | 208 | 2 | DOID:9279 (implicated_via_orthology) | |
| Disease | Language Delay | 2.61e-03 | 11 | 208 | 2 | C0023012 | |
| Disease | Language Development Disorders | 2.61e-03 | 11 | 208 | 2 | C0023014 | |
| Disease | vascular dementia (is_marker_for) | 2.61e-03 | 11 | 208 | 2 | DOID:8725 (is_marker_for) | |
| Disease | quality of life during menstruation measurement, acne | 2.61e-03 | 11 | 208 | 2 | EFO_0003894, EFO_0009366 | |
| Disease | Cleft palate, tobacco smoke exposure measurement, cleft lip, parental genotype effect measurement | 2.61e-03 | 11 | 208 | 2 | EFO_0003959, EFO_0005939, EFO_0009115, HP_0000175 | |
| Disease | Speech Delay | 2.61e-03 | 11 | 208 | 2 | C0241210 | |
| Disease | cognitive function measurement | KNTC1 SAMD9 EFR3A PKHD1 C2 SDK1 ARAP1 DPYD FLYWCH1 EEF1E1 PSD3 NBEA GRIN2A MSH5 GRIN2B FRK GUCA1A TTC21B METTL15 CPNE7 | 2.93e-03 | 1434 | 208 | 20 | EFO_0008354 |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 3.12e-03 | 12 | 208 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | survival time, Sepsis | 3.12e-03 | 12 | 208 | 2 | EFO_0000714, HP_0100806 | |
| Disease | platelet crit | TMC6 LRRK2 PDE10A ST7L ITGAX FBXO47 NCAPG2 CABLES1 DNAJA4 DQX1 AFF1 PLEC FHIP1A DNAH3 ATP13A1 | 3.23e-03 | 952 | 208 | 15 | EFO_0007985 |
| Disease | Colorectal Neoplasms | 3.64e-03 | 277 | 208 | 7 | C0009404 | |
| Disease | 3-formylindole measurement | 3.66e-03 | 13 | 208 | 2 | EFO_0801025 | |
| Disease | Muscular Dystrophy, Facioscapulohumeral | 3.66e-03 | 13 | 208 | 2 | C0238288 | |
| Disease | Schizophrenia | SPTBN2 LRRTM1 SST ITGAM TRRAP DPYD ANK3 PSD3 GRIN2A GRIN2B GRIN2D GSTT2 CSNK1E C9orf72 | 4.16e-03 | 883 | 208 | 14 | C0036341 |
| Disease | Autosomal recessive limb-girdle muscular dystrophy | 4.26e-03 | 14 | 208 | 2 | cv:C2931907 | |
| Disease | response to hydrochlorothiazide, triglyceride measurement | 4.46e-03 | 47 | 208 | 3 | EFO_0004530, EFO_0005202 | |
| Disease | S-warfarin to R-warfarin ratio measurement | 4.63e-03 | 95 | 208 | 4 | EFO_0803331 | |
| Disease | ocular hypertension, response to triamcinolone acetonide | 5.01e-03 | 49 | 208 | 3 | EFO_0006954, EFO_1001069 | |
| Disease | calcium measurement | PFDN4 GGH FAM120C SYNE2 AHSG PLEC MAP4K3 PSD3 GPX7 FRK KCNT2 | 5.21e-03 | 628 | 208 | 11 | EFO_0004838 |
| Disease | behavioural inhibitory control measurement | 5.56e-03 | 16 | 208 | 2 | EFO_0008467 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 5.56e-03 | 16 | 208 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 5.56e-03 | 16 | 208 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | cathepsin L1 measurement | 5.56e-03 | 16 | 208 | 2 | EFO_0010619 | |
| Disease | mean platelet volume | MYO5A LRRK2 ST7L CABLES1 TRANK1 SYNE2 AFF1 ATP13A3 PLEC RAC2 ARAP1 PSD3 CTR9 NNT TGS1 | 6.04e-03 | 1020 | 208 | 15 | EFO_0004584 |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 6.27e-03 | 17 | 208 | 2 | C2936862 | |
| Disease | Peripheral Nervous System Diseases | 6.58e-03 | 54 | 208 | 3 | C4721453 | |
| Disease | acute lymphoblastic leukemia (is_implicated_in) | 6.92e-03 | 55 | 208 | 3 | DOID:9952 (is_implicated_in) | |
| Disease | progression free survival, ovarian carcinoma | 7.02e-03 | 18 | 208 | 2 | EFO_0001075, EFO_0004920 | |
| Disease | Bardet-Biedl syndrome | 7.02e-03 | 18 | 208 | 2 | cv:C0752166 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FLIAKVKYLSGDIEA | 496 | Q7Z4L5 | |
| FLLNKDVGNIAKYDI | 126 | Q13075 | |
| LAALLKKQGYSTGLI | 121 | P54793 | |
| GRSKSKQLFDYLIVI | 26 | A8K979 | |
| NDTIKVYFGLKISQL | 51 | Q05901 | |
| KNVFLAYFLVSIAGL | 6 | O94766 | |
| LFLLGKHKAAIEVYN | 111 | Q96RK4 | |
| IKKAGTELVNFLSYF | 76 | P02652 | |
| QQILLSFKTAYGKDL | 236 | P50995 | |
| ILTGLGKYFQQLDKE | 446 | Q9BXY5 | |
| LEVQLFVKKYGNLFS | 66 | P51589 | |
| FVKKYGNLFSLELGD | 71 | P51589 | |
| SETLAKLYLKALAQG | 101 | Q32M84 | |
| AGQDLSAYLLKSLFK | 176 | Q9H568 | |
| SFQYLIVAIAFSKGK | 1081 | Q9H7F0 | |
| FILKYLSEKVLAAQE | 486 | P35606 | |
| LYKSNELFGSVIFKL | 946 | Q86UK0 | |
| GLEVLSFEFQKIKYS | 166 | Q9HD20 | |
| TLDKYGVQADAKLLF | 76 | Q9BQL6 | |
| TVKYLLDIGAKFQLE | 606 | Q9NU02 | |
| IKDVIGKALQYLGTF | 921 | Q12882 | |
| LYLIEKALDGQKAQS | 326 | Q008S8 | |
| LEDLYNGVTKKLALQ | 116 | Q8WW22 | |
| SAGFKLNKKLYELII | 646 | P07384 | |
| ENTLNIKKALLSGYF | 611 | Q7L7V1 | |
| LFSKLGLGKYTDVFQ | 881 | Q9H694 | |
| HQKIDDLFSGKLYLI | 191 | P60033 | |
| GILDYKNALLVAKVF | 61 | P0CG01 | |
| KDLYFLTNKIAESLG | 656 | Q14156 | |
| ALIIDGKTLKYALTF | 741 | Q9Y2Q0 | |
| LGLVATYFLGILKAK | 41 | Q8N4T4 | |
| YLFKIILIGDSNVGK | 16 | A4D1S5 | |
| LIYAGKILNDDTALK | 46 | P54727 | |
| DFETAVKKLNGKLYL | 2676 | P49792 | |
| LSIGQSLYAKAKELD | 506 | Q9H714 | |
| QGLALAKEIDSVKYL | 141 | P15153 | |
| IAKSYFRKADGVLLL | 606 | Q8IZ41 | |
| YKSTVGVDFALKVLQ | 36 | O14966 | |
| ALITAVLYKVGFFKR | 1121 | P20702 | |
| LEKLFLGYNKIQDIT | 1296 | Q6ZRR7 | |
| KLLDIENKGYLNVFS | 351 | Q969Q6 | |
| YDNQKVALLLLEKGA | 606 | Q01484 | |
| LAYAFALAGKEKQVE | 926 | Q6IE37 | |
| QKYLQDALGEFIKAL | 431 | Q5VWQ8 | |
| LLKAAFLQYCRKDLG | 521 | Q8WUM0 | |
| GYFLGANKSLLKSVE | 386 | Q8IVH8 | |
| YGKTELLGKNITFLI | 371 | Q96RG2 | |
| IKFQYKLGSQLIVTA | 76 | Q5VUB5 | |
| LLKSKFEEYVIVGLN | 226 | Q9H079 | |
| LYKKVLLGATLENDS | 11 | Q8NG48 | |
| TKTGELVQFLLNKYI | 111 | A8MXT2 | |
| NIFLTKANLIKLGDY | 181 | Q8TD19 | |
| LKKLLVASVGDDLQY | 161 | Q9H2G9 | |
| LYLCDSFVGASFLKK | 1876 | Q4ZG55 | |
| LYIFGEKSQLRNFKV | 1316 | Q86WG5 | |
| IKKNSYLVLAGLADG | 1636 | Q38SD2 | |
| SLKFLDIGYNQLKSL | 186 | Q86UE6 | |
| YLLQFDQKEKATLLG | 51 | Q9BQS8 | |
| LVLESFLYKQEKAVG | 126 | Q4VC44 | |
| EFYGDDIALLKLAQK | 556 | P06681 | |
| CSKILFEGLNITKLY | 76 | P0C7L1 | |
| AYGFKNKLIIVSAET | 776 | Q5JUK3 | |
| VLADLKVQLYAKFGS | 111 | Q9NQP4 | |
| LVANLKEGTKFYNEL | 666 | Q8WUM4 | |
| SIIKIATKADGFALY | 101 | Q9Y233 | |
| DIAIIATDLALYFKK | 661 | P35913 | |
| KGNLVYIIDFGLAKK | 141 | P48730 | |
| LDLLGNDYLVSKQVK | 1026 | Q96Q89 | |
| TLFKGKDYLDQLTQI | 221 | O15264 | |
| GLSLIGYLITKKNVF | 606 | Q5S007 | |
| LSFKKEAVLIQAGEY | 581 | P00488 | |
| SDKELKAFGIYLNKI | 1986 | Q8NG31 | |
| GSFKISALKFCLYLA | 1701 | P50748 | |
| TTKLYLAKQVFVGFL | 61 | Q92887 | |
| SLAQEKEKLLYGLAS | 811 | Q07075 | |
| AKAYGFKNKLIIVAA | 711 | Q6UVM3 | |
| IAVAVGKEAKLYLFQ | 61 | Q86V85 | |
| YLLEKFVAVLGGNIK | 446 | Q96FC9 | |
| SIAALLKEAKGLIFY | 3546 | Q9Y4D8 | |
| LNELYTGLKTAQKFL | 296 | A6NJ78 | |
| AVYIFAKKNGIPLEL | 16 | P0CG30 | |
| FKVVASGLNYKKLTD | 1791 | A2RRP1 | |
| LQKALVSGYFLKVAR | 591 | Q8TE96 | |
| FAFKGLANLEYLLLK | 246 | Q7Z2Q7 | |
| YFAIRNKKGTELLLG | 221 | P35240 | |
| YKFSLQFEELKLIGL | 936 | Q16827 | |
| LIYTLRNKEVKGAFN | 281 | P0DN82 | |
| FLNELKKDSGYVIAL | 1416 | Q96JP2 | |
| DEKTLYLALGAVKNI | 641 | Q13797 | |
| NIYKVADFGLARVFK | 366 | P42685 | |
| KDGLAYSALLKNELL | 86 | Q9UM11 | |
| GLKYNFLFLDSKLQE | 356 | Q8IUX4 | |
| KKNALLLFKGSYIEE | 621 | Q05DH4 | |
| TENGKVILKNFLYDI | 196 | P49915 | |
| AFVYFEKLALKGKLN | 541 | Q8TDN4 | |
| YISGLDVFQITLKKG | 2816 | Q9UFH2 | |
| KTSAYKVLAAALGDL | 1716 | Q8TD57 | |
| KDYEILFKSINGILF | 81 | Q92820 | |
| FQLLKLDGKFSVVYA | 116 | P02765 | |
| DKLSFLYLITGNLEK | 701 | P53621 | |
| YGFKLQSLDLLLDTK | 786 | Q8IVF7 | |
| SYKNSGVVVLADLKF | 351 | Q9UBL6 | |
| AVYIFAKKNGIPLEL | 16 | P0CG29 | |
| IQAKKALDLGTFTGY | 101 | Q86VU5 | |
| DLVKRTLFINGISKY | 236 | Q5T3F8 | |
| ALGKLLDKVQAYSTA | 6 | P17302 | |
| IYFDGKLFQSKLIKA | 851 | Q9NX05 | |
| NLGEAKKYFLASLDR | 466 | Q6PD62 | |
| LYLARALFKCGKLQE | 721 | Q6PD62 | |
| KVVSLLKEVNFYSGI | 111 | P25024 | |
| TGKAIQFALDYLFAK | 116 | Q96P44 | |
| VAAKYGKLEVANLLL | 571 | Q12955 | |
| LKDLLSKLLNSGYFE | 301 | Q6IMN6 | |
| YGFKLQSLDLLLDTK | 841 | Q96PY5 | |
| VSAAFKGLKSLEYLD | 176 | P51884 | |
| KGLKSLEYLDLSFNQ | 181 | P51884 | |
| YGKKDLLFKAQQLTD | 166 | Q86TE4 | |
| YVAALSLVLKGKVEQ | 76 | P43080 | |
| KGNKLFATENYLAAI | 296 | Q8WXU2 | |
| SLKGLADAIKLLYDA | 281 | Q5MNV8 | |
| KTKGENILLFYFDNI | 111 | A8MTL9 | |
| LVGKLKKFYEFSQRL | 86 | Q9NUQ9 | |
| GKAYAKLGFADLNLA | 91 | Q5T8I3 | |
| YDFKAVNIRGKLVSL | 26 | Q96SL4 | |
| LYSALIKLNKDNLGF | 431 | O75844 | |
| NGLILGYKILFRAKD | 1306 | Q7Z5N4 | |
| GANSIFLRLLLDKKY | 336 | Q13895 | |
| ALAQKGLYVTDQEKL | 106 | Q08AD1 | |
| GESKDLLFILTAKYN | 71 | Q16531 | |
| SFKYESGLFVQGLLK | 271 | Q96LT7 | |
| KAAFVKLYLVSQGRF | 1581 | Q5VW36 | |
| IILLNFLKGADQYKA | 341 | P56373 | |
| EKLQALDKLISLFYG | 301 | Q8NGS6 | |
| LVKQANKEYLLGSTA | 51 | O43324 | |
| AKTLLLYGADIESKN | 181 | Q6S8J7 | |
| YLLESVNKLFGEKSA | 121 | P05120 | |
| VYKVASGLKEGLSLF | 241 | O43196 | |
| GLLSYIDKLCSQKDF | 561 | A6NNL0 | |
| GLLSYIDKLCSQKDF | 561 | B1AL46 | |
| SLIAYGKLQGLLKSA | 756 | Q13423 | |
| VGATLKLLKIFQYTN | 276 | P53609 | |
| GAYLNALKIAKLLLT | 1146 | Q93008 | |
| ALKIAKLLLTAIGYG | 1151 | Q93008 | |
| FFKGYGKILEVDLKN | 21 | Q08170 | |
| KIFKGLAADQTQALY | 141 | Q13884 | |
| YFLAKIKQADVALLE | 241 | Q13049 | |
| KDGTDDFYQLKILTL | 56 | Q8N2I9 | |
| LQEILKAFDTYKALV | 6596 | Q8WXH0 | |
| LVALKADKFSGLLEY | 1336 | Q5K651 | |
| ADKFSGLLEYLIKSQ | 1341 | Q5K651 | |
| KYLALFKNSVSGIKL | 801 | Q7Z3K3 | |
| KQVLYDGKLASSIAF | 431 | Q8NFP9 | |
| LQFLGLYKKSGKLVF | 16 | Q9NR31 | |
| LYKKSGKLVFLGLDN | 21 | Q9NR31 | |
| KFNISLAKDSLLGIY | 431 | Q9UKZ4 | |
| KVFITKQGYALLVSD | 26 | Q9H9Q4 | |
| LGNKSTSKLLLAVFY | 3486 | P08F94 | |
| ANKCLLKVAGYAALL | 161 | P54920 | |
| ALITAALYKLGFFKR | 1121 | P11215 | |
| KLQYEGIFIKDSNSL | 756 | Q15459 | |
| AAKNNGIVSYDLLVK | 166 | O15091 | |
| FKLFLYDIAEGKASQ | 1111 | Q5VT25 | |
| LKAFTYINLDKAVLG | 476 | P02786 | |
| LKIANKLFGEKTYLF | 101 | P29508 | |
| YNFDFSKLLKGVISE | 576 | O60287 | |
| VFLSKPQKAALEYLE | 36 | Q9BRX8 | |
| YGKLFDFVNAKKLNI | 411 | Q08945 | |
| GKAFKYLEAVLSFIE | 986 | P51825 | |
| SLELRGFKNKLYVAV | 446 | Q96P48 | |
| VKGFFYVSLLLDILK | 916 | Q86XI2 | |
| YTFLKALKDEKLQGL | 166 | Q3C1V1 | |
| IKLFAVFYTLGNLAA | 61 | Q8WV19 | |
| LLIGFVKSIKDYGVF | 731 | Q14690 | |
| KYILGKFFALAAVNQ | 771 | Q9UNS1 | |
| FTLLDFINAVKEKYG | 966 | A0AVT1 | |
| LYLDESNALGKKFII | 21 | Q6ZYL4 | |
| AVDTAYVAKKLGLLV | 96 | O95070 | |
| FNIVYVALKSLKIGF | 201 | Q9Y397 | |
| FKLGLQDGKEYLFQA | 2296 | O15020 | |
| IFLTAKDLNAYKKQG | 201 | Q5VWJ9 | |
| YSKNALALFVLPKEG | 261 | P05543 | |
| LLLFNTTENLGKKYV | 171 | C4AMC7 | |
| FLKKYGFSSVGINLL | 71 | Q02094 | |
| LKIANKLFGEKTYQF | 101 | P48594 | |
| LFKQALKAGETIYRQ | 256 | Q8TDW4 | |
| INGLALRKTDKYGFL | 296 | Q4KMP7 | |
| NALKIAKLLLTAIGY | 1151 | O00507 | |
| YANLGVAEKTQLLKL | 2186 | O00507 | |
| AGLLLKATNEKLSVY | 2836 | Q15149 | |
| LSIYQALKKGLLSAE | 3841 | Q15149 | |
| LQAKKESELGIYLFS | 41 | Q8IYL9 | |
| QYLKGIFGDKLDLSS | 406 | Q4KWH8 | |
| YFELAKTVLIKAGGN | 1241 | A7E2V4 | |
| FLKAVGLFESYDLLK | 41 | Q8TAD4 | |
| KYKSFLDFAGLDLQI | 756 | O43149 | |
| KGVDLYVLEKAFLST | 196 | Q96S44 | |
| VIKYADNILKGFATS | 261 | Q9Y2D2 | |
| GEDKIFLINKLHSIY | 761 | Q7Z403 | |
| LNNKLKTITAYFGDL | 831 | Q96RS0 | |
| LPKNYAKSELGAVIF | 121 | Q8TB96 | |
| LSLKSLFEKYVFIGL | 161 | O15050 | |
| LSDAVLKDGYFRNLK | 131 | O60602 | |
| YGLFLTAAAQPLKAK | 451 | Q3LXA3 | |
| FKDQLKLLYSIGANV | 271 | A3KMH1 | |
| LQFLGLYKKTGKLVF | 16 | Q9Y6B6 | |
| LYKKTGKLVFLGLDN | 21 | Q9Y6B6 | |
| FSLLGKKFQYLLCVL | 171 | P51580 | |
| KLLSKFYELELNIQG | 231 | Q86UV5 | |
| LTSELGFDAAINYKK | 196 | Q8N8N7 | |
| GVDFSKDLLKALYNS | 716 | Q9NYI0 | |
| GSNVELSNLYLKLFK | 701 | Q9Y4A5 | |
| LSNLYLKLFKLVFGS | 706 | Q9Y4A5 | |
| GKYILAATLDNTLKL | 226 | P61964 | |
| AAAGKQELAKYFLAE | 41 | P61278 | |
| KTKRLLFLGAQAYLD | 41 | O15304 | |
| LLKYFSGDTLVQGIK | 66 | A0A0A6YYJ7 | |
| LKGKYIENLDNITFT | 1126 | Q7Z3T8 | |
| FYTGNLQALKGLKDL | 951 | Q9P1Q0 | |
| AKILFLALNIAYGVL | 331 | Q9BZW5 | |
| KGNLVYIIDFGLAKK | 141 | P49674 | |
| TKIFFRAGQVAYLEK | 746 | Q9Y4I1 | |
| TKIFFRAGQVAYLEK | 736 | Q9NQX4 | |
| KALFKALGLNENDYK | 736 | Q9UM54 | |
| ALGLNENDYKFGLTK | 741 | Q9UM54 | |
| AAAKGYTEVLKLLIQ | 206 | O14974 | |
| ALVSLKTGKLDAFIY | 716 | Q12879 | |
| KTGKLDAFIYDAAVL | 721 | Q12879 | |
| LKTGKLDAFIYDAAV | 721 | Q13224 | |
| TQLKAGKLDAFIYDA | 746 | O15399 |